| ENSG00000215068.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.010936581 |
Resistant |
| ENSG00000225377.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.030104869 |
Resistant |
| ENSG00000226445.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.007992824 |
Resistant |
| ENSG00000229180.4 |
Gefitinib |
Bladder urothelial carcinoma |
0.024137121 |
Resistant |
| ENSG00000230499.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.006848898 |
Resistant |
| ENSG00000230658.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.028659855 |
Resistant |
| ENSG00000230812.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.049183054 |
Resistant |
| ENSG00000231728.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.044169914 |
Resistant |
| ENSG00000234449.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.032738817 |
Resistant |
| ENSG00000235319.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.020939124 |
Resistant |
| ENSG00000236017.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.019436068 |
Resistant |
| ENSG00000236871.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.001983119 |
Resistant |
| ENSG00000247137.4 |
Gefitinib |
Bladder urothelial carcinoma |
0.018982622 |
Resistant |
| ENSG00000250697.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.049487842 |
Resistant |
| ENSG00000253893.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.027048867 |
Resistant |
| ENSG00000254165.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.041986325 |
Resistant |
| ENSG00000254343.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.042332167 |
Resistant |
| ENSG00000254862.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.007397893 |
Resistant |
| ENSG00000255495.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.041419639 |
Resistant |
| ENSG00000255843.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.025291743 |
Resistant |
| ENSG00000258825.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.005272896 |
Resistant |
| ENSG00000260635.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.026162359 |
Resistant |
| ENSG00000266644.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.030388588 |
Resistant |
| ENSG00000267470.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.037201367 |
Resistant |
| ENSG00000267476.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.046323072 |
Resistant |
| ENSG00000269652.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.041367235 |
Resistant |
| ENSG00000269942.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.015301073 |
Resistant |
| ENSG00000271553.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.020155924 |
Resistant |
| ENSG00000271778.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.020319635 |
Resistant |
| ENSG00000271803.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.019424072 |
Resistant |
| ENSG00000272449.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.014489979 |
Resistant |
| ENSG00000179219.5 |
Gefitinib |
Breast invasive carcinoma |
0.048999823 |
Resistant |
| ENSG00000182021.5 |
Gefitinib |
Breast invasive carcinoma |
0.024572006 |
Resistant |
| ENSG00000212163.2 |
Gefitinib |
Breast invasive carcinoma |
0.004649559 |
Resistant |
| ENSG00000214773.1 |
Gefitinib |
Breast invasive carcinoma |
0.040531119 |
Resistant |
| ENSG00000228540.1 |
Gefitinib |
Breast invasive carcinoma |
0.028294348 |
Resistant |
| ENSG00000229190.1 |
Gefitinib |
Breast invasive carcinoma |
0.024010257 |
Resistant |
| ENSG00000229852.2 |
Gefitinib |
Breast invasive carcinoma |
0.009858436 |
Resistant |
| ENSG00000230836.1 |
Gefitinib |
Breast invasive carcinoma |
0.045962418 |
Resistant |
| ENSG00000231612.1 |
Gefitinib |
Breast invasive carcinoma |
0.044790992 |
Resistant |
| ENSG00000232600.2 |
Gefitinib |
Breast invasive carcinoma |
0.037542872 |
Resistant |
| ENSG00000232909.1 |
Gefitinib |
Breast invasive carcinoma |
0.017942149 |
Resistant |
| ENSG00000233033.1 |
Gefitinib |
Breast invasive carcinoma |
0.020414089 |
Resistant |
| ENSG00000234215.2 |
Gefitinib |
Breast invasive carcinoma |
0.047076985 |
Resistant |
| ENSG00000234753.1 |
Gefitinib |
Breast invasive carcinoma |
0.048607094 |
Resistant |
| ENSG00000237976.1 |
Gefitinib |
Breast invasive carcinoma |
0.044496515 |
Resistant |
| ENSG00000239377.1 |
Gefitinib |
Breast invasive carcinoma |
0.006401021 |
Resistant |
| ENSG00000242242.1 |
Gefitinib |
Breast invasive carcinoma |
0.033923047 |
Resistant |
| ENSG00000242516.1 |
Gefitinib |
Breast invasive carcinoma |
0.031612162 |
Resistant |
| ENSG00000246859.2 |
Gefitinib |
Breast invasive carcinoma |
0.049340494 |
Resistant |
| ENSG00000248996.1 |
Gefitinib |
Breast invasive carcinoma |
0.042838224 |
Resistant |
| ENSG00000249252.1 |
Gefitinib |
Breast invasive carcinoma |
0.01234295 |
Resistant |
| ENSG00000249476.1 |
Gefitinib |
Breast invasive carcinoma |
0.032275949 |
Resistant |
| ENSG00000253837.1 |
Gefitinib |
Breast invasive carcinoma |
0.032348841 |
Resistant |
| ENSG00000257279.1 |
Gefitinib |
Breast invasive carcinoma |
0.038426366 |
Resistant |
| ENSG00000257698.1 |
Gefitinib |
Breast invasive carcinoma |
0.025784371 |
Resistant |
| ENSG00000258086.1 |
Gefitinib |
Breast invasive carcinoma |
0.007133009 |
Resistant |
| ENSG00000259209.1 |
Gefitinib |
Breast invasive carcinoma |
0.021022451 |
Resistant |
| ENSG00000260269.1 |
Gefitinib |
Breast invasive carcinoma |
0.032541809 |
Resistant |
| ENSG00000260475.1 |
Gefitinib |
Breast invasive carcinoma |
0.049011015 |
Resistant |
| ENSG00000261373.1 |
Gefitinib |
Breast invasive carcinoma |
0.020291257 |
Resistant |
| ENSG00000261428.1 |
Gefitinib |
Breast invasive carcinoma |
0.047141141 |
Resistant |
| ENSG00000261438.1 |
Gefitinib |
Breast invasive carcinoma |
0.016542227 |
Resistant |
| ENSG00000261801.1 |
Gefitinib |
Breast invasive carcinoma |
0.047748419 |
Resistant |
| ENSG00000262434.1 |
Gefitinib |
Breast invasive carcinoma |
0.035689728 |
Resistant |
| ENSG00000262445.3 |
Gefitinib |
Breast invasive carcinoma |
0.043187212 |
Resistant |
| ENSG00000263388.1 |
Gefitinib |
Breast invasive carcinoma |
0.048463176 |
Resistant |
| ENSG00000266965.1 |
Gefitinib |
Breast invasive carcinoma |
0.004592198 |
Resistant |
| ENSG00000267505.1 |
Gefitinib |
Breast invasive carcinoma |
0.04069665 |
Resistant |
| ENSG00000267765.1 |
Gefitinib |
Breast invasive carcinoma |
0.033335321 |
Resistant |
| ENSG00000267787.1 |
Gefitinib |
Breast invasive carcinoma |
0.048962665 |
Resistant |
| ENSG00000269951.1 |
Gefitinib |
Breast invasive carcinoma |
0.019931041 |
Resistant |
| ENSG00000271788.1 |
Gefitinib |
Breast invasive carcinoma |
0.03512575 |
Resistant |
| ENSG00000272316.1 |
Gefitinib |
Breast invasive carcinoma |
0.0444056 |
Resistant |
| ENSG00000272374.1 |
Gefitinib |
Breast invasive carcinoma |
0.005816353 |
Resistant |
| ENSG00000272677.1 |
Gefitinib |
Breast invasive carcinoma |
0.01331022 |
Resistant |
| ENSG00000272695.1 |
Gefitinib |
Breast invasive carcinoma |
0.027391691 |
Resistant |
| ENSG00000272977.1 |
Gefitinib |
Breast invasive carcinoma |
0.032782348 |
Resistant |
| ENSG00000181097.5 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029799872 |
Resistant |
| ENSG00000186019.10 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017853625 |
Resistant |
| ENSG00000225725.4 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045163687 |
Resistant |
| ENSG00000227704.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042690528 |
Resistant |
| ENSG00000227888.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027034356 |
Resistant |
| ENSG00000228010.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003336182 |
Resistant |
| ENSG00000228204.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04702344 |
Resistant |
| ENSG00000228486.5 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031469786 |
Resistant |
| ENSG00000228544.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034229629 |
Resistant |
| ENSG00000228793.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017602083 |
Resistant |
| ENSG00000228878.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025172143 |
Resistant |
| ENSG00000229852.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002730892 |
Resistant |
| ENSG00000230289.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039514717 |
Resistant |
| ENSG00000230798.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.00699548 |
Resistant |
| ENSG00000231407.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047254641 |
Resistant |
| ENSG00000231871.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040314241 |
Resistant |
| ENSG00000232940.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034201278 |
Resistant |
| ENSG00000233593.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036879238 |
Resistant |
| ENSG00000234695.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030413032 |
Resistant |
| ENSG00000235092.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037057914 |
Resistant |
| ENSG00000235121.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030807366 |
Resistant |
| ENSG00000235586.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042655112 |
Resistant |
| ENSG00000236206.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039885226 |
Resistant |
| ENSG00000236383.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005407813 |
Resistant |
| ENSG00000237502.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031531134 |
Resistant |
| ENSG00000239774.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008910848 |
Resistant |
| ENSG00000240291.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03706695 |
Resistant |
| ENSG00000245311.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028823153 |
Resistant |
| ENSG00000246465.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020592944 |
Resistant |
| ENSG00000246731.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005374951 |
Resistant |
| ENSG00000247372.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017098671 |
Resistant |
| ENSG00000248515.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038614895 |
Resistant |
| ENSG00000248925.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027259383 |
Resistant |
| ENSG00000249825.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049239123 |
Resistant |
| ENSG00000250012.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028052983 |
Resistant |
| ENSG00000250220.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.026637422 |
Resistant |
| ENSG00000250846.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.012481285 |
Resistant |
| ENSG00000253618.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039241272 |
Resistant |
| ENSG00000254338.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000497636 |
Resistant |
| ENSG00000255669.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020583229 |
Resistant |
| ENSG00000257497.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02619845 |
Resistant |
| ENSG00000258809.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020414442 |
Resistant |
| ENSG00000259088.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037591949 |
Resistant |
| ENSG00000259762.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.041995873 |
Resistant |
| ENSG00000259826.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032508564 |
Resistant |
| ENSG00000260572.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04748258 |
Resistant |
| ENSG00000260618.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019488185 |
Resistant |
| ENSG00000260641.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016903184 |
Resistant |
| ENSG00000260891.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045696792 |
Resistant |
| ENSG00000262172.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031332085 |
Resistant |
| ENSG00000262202.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016007084 |
Resistant |
| ENSG00000262410.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03412593 |
Resistant |
| ENSG00000263214.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020290271 |
Resistant |
| ENSG00000264235.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005961178 |
Resistant |
| ENSG00000264569.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045329586 |
Resistant |
| ENSG00000267136.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022756297 |
Resistant |
| ENSG00000268230.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030013908 |
Resistant |
| ENSG00000269246.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040021356 |
Resistant |
| ENSG00000269352.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044867261 |
Resistant |
| ENSG00000269896.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043464678 |
Resistant |
| ENSG00000271738.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015618604 |
Resistant |
| ENSG00000271751.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046783968 |
Resistant |
| ENSG00000271815.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039889211 |
Resistant |
| ENSG00000272005.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040330745 |
Resistant |
| ENSG00000272123.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02760999 |
Resistant |
| ENSG00000272161.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049503684 |
Resistant |
| ENSG00000273066.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044285518 |
Resistant |
| ENSG00000177993.3 |
Gefitinib |
Esophageal cancer |
0.024488537 |
Resistant |
| ENSG00000196364.7 |
Gefitinib |
Esophageal cancer |
0.00020747 |
Resistant |
| ENSG00000198221.7 |
Gefitinib |
Esophageal cancer |
0.005854755 |
Resistant |
| ENSG00000223462.2 |
Gefitinib |
Esophageal cancer |
0.01706126 |
Resistant |
| ENSG00000224745.1 |
Gefitinib |
Esophageal cancer |
0.012399356 |
Resistant |
| ENSG00000225285.1 |
Gefitinib |
Esophageal cancer |
0.003321666 |
Resistant |
| ENSG00000225527.1 |
Gefitinib |
Esophageal cancer |
0.038108354 |
Resistant |
| ENSG00000228686.2 |
Gefitinib |
Esophageal cancer |
0.008286019 |
Resistant |
| ENSG00000229539.1 |
Gefitinib |
Esophageal cancer |
0.013004397 |
Resistant |
| ENSG00000230751.1 |
Gefitinib |
Esophageal cancer |
0.002954208 |
Resistant |
| ENSG00000231172.2 |
Gefitinib |
Esophageal cancer |
0.01442505 |
Resistant |
| ENSG00000231201.1 |
Gefitinib |
Esophageal cancer |
0.049587798 |
Resistant |
| ENSG00000232081.1 |
Gefitinib |
Esophageal cancer |
0.024928331 |
Resistant |
| ENSG00000232290.1 |
Gefitinib |
Esophageal cancer |
0.030343236 |
Resistant |
| ENSG00000232725.1 |
Gefitinib |
Esophageal cancer |
0.033116229 |
Resistant |
| ENSG00000232739.1 |
Gefitinib |
Esophageal cancer |
0.000172248 |
Resistant |
| ENSG00000233760.1 |
Gefitinib |
Esophageal cancer |
0.004839806 |
Resistant |
| ENSG00000233845.1 |
Gefitinib |
Esophageal cancer |
0.003064462 |
Resistant |
| ENSG00000233993.1 |
Gefitinib |
Esophageal cancer |
0.014086683 |
Resistant |
| ENSG00000234678.1 |
Gefitinib |
Esophageal cancer |
0.000518711 |
Resistant |
| ENSG00000234690.2 |
Gefitinib |
Esophageal cancer |
0.022324219 |
Resistant |
| ENSG00000236301.4 |
Gefitinib |
Esophageal cancer |
0.04448949 |
Resistant |
| ENSG00000236305.1 |
Gefitinib |
Esophageal cancer |
0.01806242 |
Resistant |
| ENSG00000236753.1 |
Gefitinib |
Esophageal cancer |
0.000301977 |
Resistant |
| ENSG00000236824.1 |
Gefitinib |
Esophageal cancer |
0.020375013 |
Resistant |
| ENSG00000237126.4 |
Gefitinib |
Esophageal cancer |
0.001077224 |
Resistant |
| ENSG00000238018.1 |
Gefitinib |
Esophageal cancer |
0.023767295 |
Resistant |
| ENSG00000238140.1 |
Gefitinib |
Esophageal cancer |
0.003572746 |
Resistant |
| ENSG00000239552.2 |
Gefitinib |
Esophageal cancer |
0.012227797 |
Resistant |
| ENSG00000241544.1 |
Gefitinib |
Esophageal cancer |
0.009968169 |
Resistant |
| ENSG00000243629.1 |
Gefitinib |
Esophageal cancer |
0.000130452 |
Resistant |
| ENSG00000243902.2 |
Gefitinib |
Esophageal cancer |
0.027674393 |
Resistant |
| ENSG00000244791.2 |
Gefitinib |
Esophageal cancer |
0.000970834 |
Resistant |
| ENSG00000247381.2 |
Gefitinib |
Esophageal cancer |
0.0000117 |
Resistant |
| ENSG00000248514.1 |
Gefitinib |
Esophageal cancer |
0.002222849 |
Resistant |
| ENSG00000253880.1 |
Gefitinib |
Esophageal cancer |
0.04369958 |
Resistant |
| ENSG00000253930.1 |
Gefitinib |
Esophageal cancer |
0.000484669 |
Resistant |
| ENSG00000254432.1 |
Gefitinib |
Esophageal cancer |
0.009232322 |
Resistant |
| ENSG00000255153.1 |
Gefitinib |
Esophageal cancer |
0.033295989 |
Resistant |
| ENSG00000257135.1 |
Gefitinib |
Esophageal cancer |
0.000138077 |
Resistant |
| ENSG00000257191.1 |
Gefitinib |
Esophageal cancer |
0.020818063 |
Resistant |
| ENSG00000257702.3 |
Gefitinib |
Esophageal cancer |
0.002712486 |
Resistant |
| ENSG00000258175.1 |
Gefitinib |
Esophageal cancer |
0.007524748 |
Resistant |
| ENSG00000259054.1 |
Gefitinib |
Esophageal cancer |
0.001660555 |
Resistant |
| ENSG00000259242.2 |
Gefitinib |
Esophageal cancer |
0.000897425 |
Resistant |
| ENSG00000259396.1 |
Gefitinib |
Esophageal cancer |
0.0000201 |
Resistant |
| ENSG00000259514.1 |
Gefitinib |
Esophageal cancer |
0.022546176 |
Resistant |
| ENSG00000260592.1 |
Gefitinib |
Esophageal cancer |
0.012029631 |
Resistant |
| ENSG00000260742.1 |
Gefitinib |
Esophageal cancer |
0.019595582 |
Resistant |
| ENSG00000260837.1 |
Gefitinib |
Esophageal cancer |
0.015555033 |
Resistant |
| ENSG00000261338.1 |
Gefitinib |
Esophageal cancer |
0.005885524 |
Resistant |
| ENSG00000262294.1 |
Gefitinib |
Esophageal cancer |
0.002616608 |
Resistant |
| ENSG00000262823.1 |
Gefitinib |
Esophageal cancer |
0.004940192 |
Resistant |
| ENSG00000263280.1 |
Gefitinib |
Esophageal cancer |
0.000954732 |
Resistant |
| ENSG00000263893.2 |
Gefitinib |
Esophageal cancer |
0.006943762 |
Resistant |
| ENSG00000266835.1 |
Gefitinib |
Esophageal cancer |
0.002331942 |
Resistant |
| ENSG00000267838.1 |
Gefitinib |
Esophageal cancer |
0.048363273 |
Resistant |
| ENSG00000268913.1 |
Gefitinib |
Esophageal cancer |
0.020189222 |
Resistant |
| ENSG00000269873.1 |
Gefitinib |
Esophageal cancer |
0.035021376 |
Resistant |
| ENSG00000269887.1 |
Gefitinib |
Esophageal cancer |
0.010455984 |
Resistant |
| ENSG00000269976.1 |
Gefitinib |
Esophageal cancer |
0.021669159 |
Resistant |
| ENSG00000269990.1 |
Gefitinib |
Esophageal cancer |
0.008136079 |
Resistant |
| ENSG00000270018.1 |
Gefitinib |
Esophageal cancer |
0.04845403 |
Resistant |
| ENSG00000270460.1 |
Gefitinib |
Esophageal cancer |
0.000194585 |
Resistant |
| ENSG00000270557.1 |
Gefitinib |
Esophageal cancer |
0.046901878 |
Resistant |
| ENSG00000272308.1 |
Gefitinib |
Esophageal cancer |
0.011339391 |
Resistant |
| ENSG00000272354.1 |
Gefitinib |
Esophageal cancer |
0.018740846 |
Resistant |
| ENSG00000272440.1 |
Gefitinib |
Esophageal cancer |
0.018116988 |
Resistant |
| ENSG00000272449.1 |
Gefitinib |
Esophageal cancer |
0.024943351 |
Resistant |
| ENSG00000272544.1 |
Gefitinib |
Esophageal cancer |
0.043173047 |
Resistant |
| ENSG00000272567.1 |
Gefitinib |
Esophageal cancer |
0.045529419 |
Resistant |
| ENSG00000272744.1 |
Gefitinib |
Esophageal cancer |
0.025395903 |
Resistant |
| ENSG00000272832.1 |
Gefitinib |
Esophageal cancer |
0.002902563 |
Resistant |
| ENSG00000273213.1 |
Gefitinib |
Esophageal cancer |
0.016502316 |
Resistant |
| ENSG00000224621.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.018435606 |
Resistant |
| ENSG00000225111.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.000319118 |
Resistant |
| ENSG00000225138.3 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.034355574 |
Resistant |
| ENSG00000227811.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.038184809 |
Resistant |
| ENSG00000230082.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.02309875 |
Resistant |
| ENSG00000230499.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.040846656 |
Resistant |
| ENSG00000231948.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.04678069 |
Resistant |
| ENSG00000232259.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.033538919 |
Resistant |
| ENSG00000234292.3 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.04619419 |
Resistant |
| ENSG00000248125.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.034964988 |
Resistant |
| ENSG00000249584.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.047030923 |
Resistant |
| ENSG00000250740.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.017580822 |
Resistant |
| ENSG00000251281.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.037976977 |
Resistant |
| ENSG00000253121.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.042058256 |
Resistant |
| ENSG00000253476.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.029687787 |
Resistant |
| ENSG00000255325.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.045009328 |
Resistant |
| ENSG00000258777.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.017748237 |
Resistant |
| ENSG00000259038.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.043261852 |
Resistant |
| ENSG00000259758.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.041641141 |
Resistant |
| ENSG00000260021.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.00229295 |
Resistant |
| ENSG00000260936.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.008771132 |
Resistant |
| ENSG00000266926.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.009085511 |
Resistant |
| ENSG00000267249.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.008033466 |
Resistant |
| ENSG00000267567.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.038478572 |
Resistant |
| ENSG00000268746.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.017545738 |
Resistant |
| ENSG00000270346.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.000381703 |
Resistant |
| ENSG00000271538.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.014426711 |
Resistant |
| ENSG00000271882.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.047111633 |
Resistant |
| ENSG00000272092.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.024892167 |
Resistant |
| ENSG00000272787.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.041307854 |
Resistant |
| ENSG00000196668.3 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.048609127 |
Resistant |
| ENSG00000215023.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.006304105 |
Resistant |
| ENSG00000215458.4 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.017317908 |
Resistant |
| ENSG00000223598.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.023109031 |
Resistant |
| ENSG00000224597.5 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.036389569 |
Resistant |
| ENSG00000225218.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.021463633 |
Resistant |
| ENSG00000225470.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.00445718 |
Resistant |
| ENSG00000226913.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.023110927 |
Resistant |
| ENSG00000227698.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.045053355 |
Resistant |
| ENSG00000227953.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.04338422 |
Resistant |
| ENSG00000228126.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.047765018 |
Resistant |
| ENSG00000228363.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.046060521 |
Resistant |
| ENSG00000229388.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.03961553 |
Resistant |
| ENSG00000229525.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.015899606 |
Resistant |
| ENSG00000229955.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.000700331 |
Resistant |
| ENSG00000230082.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.013658002 |
Resistant |
| ENSG00000230561.3 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.014581564 |
Resistant |
| ENSG00000230844.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.041765022 |
Resistant |
| ENSG00000231298.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.005070701 |
Resistant |
| ENSG00000231607.4 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.029843454 |
Resistant |
| ENSG00000233509.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.004877329 |
Resistant |
| ENSG00000234019.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.046925952 |
Resistant |
| ENSG00000235527.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.039637674 |
Resistant |
| ENSG00000235954.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.011180996 |
Resistant |
| ENSG00000237416.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.020685564 |
Resistant |
| ENSG00000237481.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.037955481 |
Resistant |
| ENSG00000245573.3 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.033407551 |
Resistant |
| ENSG00000246560.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.018346316 |
Resistant |
| ENSG00000248866.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.03961292 |
Resistant |
| ENSG00000249476.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.034258721 |
Resistant |
| ENSG00000250900.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.017576616 |
Resistant |
| ENSG00000251556.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.009174113 |
Resistant |
| ENSG00000253948.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.037301647 |
Resistant |
| ENSG00000254791.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.020990365 |
Resistant |
| ENSG00000258658.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.042274537 |
Resistant |
| ENSG00000259212.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.022469731 |
Resistant |
| ENSG00000260248.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.025498922 |
Resistant |
| ENSG00000260388.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.010635755 |
Resistant |
| ENSG00000260792.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.043482106 |
Resistant |
| ENSG00000261040.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.041205328 |
Resistant |
| ENSG00000261404.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.044034086 |
Resistant |
| ENSG00000267798.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.007114832 |
Resistant |
| ENSG00000268061.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.014709526 |
Resistant |
| ENSG00000269574.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.048139378 |
Resistant |
| ENSG00000269688.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.015889576 |
Resistant |
| ENSG00000270083.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.018020893 |
Resistant |
| ENSG00000270141.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.010872551 |
Resistant |
| ENSG00000270361.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.00313252 |
Resistant |
| ENSG00000272505.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.042788436 |
Resistant |
| ENSG00000272529.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.037291846 |
Resistant |
| ENSG00000272588.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.046714731 |
Resistant |
| ENSG00000273059.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.037182579 |
Resistant |
| ENSG00000273338.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.041408356 |
Resistant |
| ENSG00000118412.8 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.001382419 |
Resistant |
| ENSG00000149656.4 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.00546471 |
Resistant |
| ENSG00000170590.4 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.016304362 |
Resistant |
| ENSG00000197332.7 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.028686691 |
Resistant |
| ENSG00000214955.5 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.045283527 |
Resistant |
| ENSG00000215769.4 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.045868265 |
Resistant |
| ENSG00000217576.7 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.01842414 |
Resistant |
| ENSG00000223598.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.009518079 |
Resistant |
| ENSG00000224478.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.025052754 |
Resistant |
| ENSG00000225163.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.033123811 |
Resistant |
| ENSG00000225721.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.0423713 |
Resistant |
| ENSG00000225767.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019100531 |
Resistant |
| ENSG00000225948.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.037610233 |
Resistant |
| ENSG00000226352.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.040599322 |
Resistant |
| ENSG00000226851.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.024567219 |
Resistant |
| ENSG00000227409.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.021930699 |
Resistant |
| ENSG00000227598.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.034094202 |
Resistant |
| ENSG00000227953.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.00497834 |
Resistant |
| ENSG00000228060.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.028404966 |
Resistant |
| ENSG00000228107.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.047594136 |
Resistant |
| ENSG00000228629.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.033339072 |
Resistant |
| ENSG00000228643.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.035557316 |
Resistant |
| ENSG00000228737.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.023812641 |
Resistant |
| ENSG00000228906.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.039218828 |
Resistant |
| ENSG00000228988.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.022201702 |
Resistant |
| ENSG00000229780.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.026734829 |
Resistant |
| ENSG00000230013.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.024185363 |
Resistant |
| ENSG00000230021.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.043479333 |
Resistant |
| ENSG00000230124.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.042640647 |
Resistant |
| ENSG00000230131.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.035689972 |
Resistant |
| ENSG00000230303.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.018776884 |
Resistant |
| ENSG00000231113.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.021188789 |
Resistant |
| ENSG00000231889.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.024834551 |
Resistant |
| ENSG00000232487.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030883218 |
Resistant |
| ENSG00000232648.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.016645327 |
Resistant |
| ENSG00000232712.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.002944932 |
Resistant |
| ENSG00000233848.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.049412685 |
Resistant |
| ENSG00000234084.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.004661015 |
Resistant |
| ENSG00000235066.4 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030558281 |
Resistant |
| ENSG00000235091.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.026181293 |
Resistant |
| ENSG00000236016.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.017892318 |
Resistant |
| ENSG00000236703.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.004687819 |
Resistant |
| ENSG00000236889.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.048842949 |
Resistant |
| ENSG00000236986.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.020373243 |
Resistant |
| ENSG00000237373.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.010798734 |
Resistant |
| ENSG00000237945.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.041566567 |
Resistant |
| ENSG00000239664.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.026120853 |
Resistant |
| ENSG00000239705.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030426253 |
Resistant |
| ENSG00000240754.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.042708358 |
Resistant |
| ENSG00000240758.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.007217318 |
Resistant |
| ENSG00000242798.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.028454124 |
Resistant |
| ENSG00000247679.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.018751033 |
Resistant |
| ENSG00000248774.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.023184574 |
Resistant |
| ENSG00000249084.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.003296663 |
Resistant |
| ENSG00000249476.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.032882611 |
Resistant |
| ENSG00000249492.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.04400625 |
Resistant |
| ENSG00000249572.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019429251 |
Resistant |
| ENSG00000249786.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.012636316 |
Resistant |
| ENSG00000249825.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.025249515 |
Resistant |
| ENSG00000250027.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.018035019 |
Resistant |
| ENSG00000250075.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.012100885 |
Resistant |
| ENSG00000250765.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.020010877 |
Resistant |
| ENSG00000251298.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.039191799 |
Resistant |
| ENSG00000251455.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030474897 |
Resistant |
| ENSG00000251556.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.00521452 |
Resistant |
| ENSG00000251675.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.036812391 |
Resistant |
| ENSG00000253708.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.010300443 |
Resistant |
| ENSG00000254162.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030258282 |
Resistant |
| ENSG00000254362.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.04880437 |
Resistant |
| ENSG00000254900.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.025811024 |
Resistant |
| ENSG00000255474.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.009827544 |
Resistant |
| ENSG00000255557.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019106936 |
Resistant |
| ENSG00000255893.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.004464178 |
Resistant |
| ENSG00000256237.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.025308225 |
Resistant |
| ENSG00000256278.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.026705041 |
Resistant |
| ENSG00000256789.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.025224965 |
Resistant |
| ENSG00000256973.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.040454971 |
Resistant |
| ENSG00000258086.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.037262798 |
Resistant |
| ENSG00000258172.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.037661544 |
Resistant |
| ENSG00000258199.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030621727 |
Resistant |
| ENSG00000258344.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.003705336 |
Resistant |
| ENSG00000258673.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.014451325 |
Resistant |
| ENSG00000258711.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.024555133 |
Resistant |
| ENSG00000259418.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.008972885 |
Resistant |
| ENSG00000259426.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.046328097 |
Resistant |
| ENSG00000259553.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.00942341 |
Resistant |
| ENSG00000259606.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030105167 |
Resistant |
| ENSG00000260252.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019640783 |
Resistant |
| ENSG00000260534.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.036561074 |
Resistant |
| ENSG00000260536.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.002747784 |
Resistant |
| ENSG00000260545.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.049770878 |
Resistant |
| ENSG00000260589.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030759762 |
Resistant |
| ENSG00000260613.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.016724729 |
Resistant |
| ENSG00000260645.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.029200339 |
Resistant |
| ENSG00000260672.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.044701096 |
Resistant |
| ENSG00000260855.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.003677364 |
Resistant |
| ENSG00000261019.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.038780318 |
Resistant |
| ENSG00000261049.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.038008234 |
Resistant |
| ENSG00000261068.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.016221372 |
Resistant |
| ENSG00000261069.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.049160826 |
Resistant |
| ENSG00000261200.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.041842395 |
Resistant |
| ENSG00000261211.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.011475775 |
Resistant |
| ENSG00000261254.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.017108277 |
Resistant |
| ENSG00000261404.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.045538793 |
Resistant |
| ENSG00000261451.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.032769496 |
Resistant |
| ENSG00000261775.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.002954505 |
Resistant |
| ENSG00000261799.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.041433268 |
Resistant |
| ENSG00000261916.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019494808 |
Resistant |
| ENSG00000262115.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.045429682 |
Resistant |
| ENSG00000262678.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.014814816 |
Resistant |
| ENSG00000262692.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.003428969 |
Resistant |
| ENSG00000262772.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.030963686 |
Resistant |
| ENSG00000262903.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.027279245 |
Resistant |
| ENSG00000263370.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.007358092 |
Resistant |
| ENSG00000263627.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.016437087 |
Resistant |
| ENSG00000264107.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.042759106 |
Resistant |
| ENSG00000264829.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.045720131 |
Resistant |
| ENSG00000265218.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.012759809 |
Resistant |
| ENSG00000265394.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.047064136 |
Resistant |
| ENSG00000265443.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.048625931 |
Resistant |
| ENSG00000265728.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.038907944 |
Resistant |
| ENSG00000265791.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.00845357 |
Resistant |
| ENSG00000266601.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.004364759 |
Resistant |
| ENSG00000266644.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.001473818 |
Resistant |
| ENSG00000266844.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.029457486 |
Resistant |
| ENSG00000266912.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.036890186 |
Resistant |
| ENSG00000266918.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019247705 |
Resistant |
| ENSG00000267006.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.004450767 |
Resistant |
| ENSG00000267136.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.032633187 |
Resistant |
| ENSG00000267174.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.046411822 |
Resistant |
| ENSG00000267198.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.008718343 |
Resistant |
| ENSG00000267246.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.019744481 |
Resistant |
| ENSG00000267437.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.03217678 |
Resistant |
| ENSG00000267565.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.047483568 |
Resistant |
| ENSG00000267682.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.029716444 |
Resistant |
| ENSG00000267940.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.025141035 |
Resistant |
| ENSG00000268743.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.043754398 |
Resistant |
| ENSG00000268756.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.017212969 |
Resistant |
| ENSG00000268802.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.002748212 |
Resistant |
| ENSG00000269535.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.03101622 |
Resistant |
| ENSG00000269656.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.035484025 |
Resistant |
| ENSG00000270174.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.034392428 |
Resistant |
| ENSG00000271643.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.033186142 |
Resistant |
| ENSG00000271820.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.038299671 |
Resistant |
| ENSG00000271871.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.035183683 |
Resistant |
| ENSG00000271963.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.013032523 |
Resistant |
| ENSG00000272070.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.01851012 |
Resistant |
| ENSG00000272240.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.018891379 |
Resistant |
| ENSG00000272316.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.038773362 |
Resistant |
| ENSG00000272334.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.034753665 |
Resistant |
| ENSG00000272562.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.014066156 |
Resistant |
| ENSG00000272812.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.022527717 |
Resistant |
| ENSG00000272905.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.023422074 |
Resistant |
| ENSG00000273007.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.031296826 |
Resistant |
| ENSG00000273033.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.037412841 |
Resistant |
| ENSG00000273313.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.003900714 |
Resistant |
| ENSG00000273356.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.012582116 |
Resistant |
| ENSG00000273373.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.039206976 |
Resistant |
| ENSG00000204054.7 |
Gefitinib |
Brain lower grade glioma |
0.045969745 |
Resistant |
| ENSG00000213863.2 |
Gefitinib |
Brain lower grade glioma |
0.038658286 |
Resistant |
| ENSG00000214401.4 |
Gefitinib |
Brain lower grade glioma |
0.048283618 |
Resistant |
| ENSG00000215447.3 |
Gefitinib |
Brain lower grade glioma |
0.030087841 |
Resistant |
| ENSG00000223461.1 |
Gefitinib |
Brain lower grade glioma |
0.043849118 |
Resistant |
| ENSG00000223768.1 |
Gefitinib |
Brain lower grade glioma |
0.034875514 |
Resistant |
| ENSG00000223821.1 |
Gefitinib |
Brain lower grade glioma |
0.028381043 |
Resistant |
| ENSG00000224189.2 |
Gefitinib |
Brain lower grade glioma |
0.045428187 |
Resistant |
| ENSG00000224969.1 |
Gefitinib |
Brain lower grade glioma |
0.037256827 |
Resistant |
| ENSG00000226453.1 |
Gefitinib |
Brain lower grade glioma |
0.019387926 |
Resistant |
| ENSG00000226833.1 |
Gefitinib |
Brain lower grade glioma |
0.032356011 |
Resistant |
| ENSG00000228452.1 |
Gefitinib |
Brain lower grade glioma |
0.037393451 |
Resistant |
| ENSG00000229444.1 |
Gefitinib |
Brain lower grade glioma |
0.048040656 |
Resistant |
| ENSG00000229848.1 |
Gefitinib |
Brain lower grade glioma |
0.022706073 |
Resistant |
| ENSG00000230487.3 |
Gefitinib |
Brain lower grade glioma |
0.021512629 |
Resistant |
| ENSG00000230550.1 |
Gefitinib |
Brain lower grade glioma |
0.029325647 |
Resistant |
| ENSG00000231789.2 |
Gefitinib |
Brain lower grade glioma |
0.028643357 |
Resistant |
| ENSG00000231890.3 |
Gefitinib |
Brain lower grade glioma |
0.023946958 |
Resistant |
| ENSG00000232633.3 |
Gefitinib |
Brain lower grade glioma |
0.045463724 |
Resistant |
| ENSG00000233554.1 |
Gefitinib |
Brain lower grade glioma |
0.038721321 |
Resistant |
| ENSG00000235151.1 |
Gefitinib |
Brain lower grade glioma |
0.0385352 |
Resistant |
| ENSG00000235823.1 |
Gefitinib |
Brain lower grade glioma |
0.042005039 |
Resistant |
| ENSG00000236051.2 |
Gefitinib |
Brain lower grade glioma |
0.007413918 |
Resistant |
| ENSG00000236772.1 |
Gefitinib |
Brain lower grade glioma |
0.046591116 |
Resistant |
| ENSG00000238260.1 |
Gefitinib |
Brain lower grade glioma |
0.037152645 |
Resistant |
| ENSG00000248599.1 |
Gefitinib |
Brain lower grade glioma |
0.032769731 |
Resistant |
| ENSG00000249216.1 |
Gefitinib |
Brain lower grade glioma |
0.008674544 |
Resistant |
| ENSG00000249609.1 |
Gefitinib |
Brain lower grade glioma |
0.041328348 |
Resistant |
| ENSG00000251661.3 |
Gefitinib |
Brain lower grade glioma |
0.035287061 |
Resistant |
| ENSG00000254631.1 |
Gefitinib |
Brain lower grade glioma |
0.042143675 |
Resistant |
| ENSG00000255867.1 |
Gefitinib |
Brain lower grade glioma |
0.016668746 |
Resistant |
| ENSG00000257366.1 |
Gefitinib |
Brain lower grade glioma |
0.035271358 |
Resistant |
| ENSG00000259065.1 |
Gefitinib |
Brain lower grade glioma |
0.04887914 |
Resistant |
| ENSG00000259319.1 |
Gefitinib |
Brain lower grade glioma |
0.027188761 |
Resistant |
| ENSG00000259343.1 |
Gefitinib |
Brain lower grade glioma |
0.007148322 |
Resistant |
| ENSG00000259520.1 |
Gefitinib |
Brain lower grade glioma |
0.041251786 |
Resistant |
| ENSG00000259705.1 |
Gefitinib |
Brain lower grade glioma |
0.030109786 |
Resistant |
| ENSG00000260193.1 |
Gefitinib |
Brain lower grade glioma |
0.029546462 |
Resistant |
| ENSG00000260231.1 |
Gefitinib |
Brain lower grade glioma |
0.01939174 |
Resistant |
| ENSG00000260517.1 |
Gefitinib |
Brain lower grade glioma |
0.03924588 |
Resistant |
| ENSG00000261280.2 |
Gefitinib |
Brain lower grade glioma |
0.048864417 |
Resistant |
| ENSG00000261827.1 |
Gefitinib |
Brain lower grade glioma |
0.041405526 |
Resistant |
| ENSG00000262089.1 |
Gefitinib |
Brain lower grade glioma |
0.007582912 |
Resistant |
| ENSG00000262585.1 |
Gefitinib |
Brain lower grade glioma |
0.023979562 |
Resistant |
| ENSG00000263004.1 |
Gefitinib |
Brain lower grade glioma |
0.025972266 |
Resistant |
| ENSG00000264673.1 |
Gefitinib |
Brain lower grade glioma |
0.019498809 |
Resistant |
| ENSG00000265445.1 |
Gefitinib |
Brain lower grade glioma |
0.027918355 |
Resistant |
| ENSG00000265688.1 |
Gefitinib |
Brain lower grade glioma |
0.046391903 |
Resistant |
| ENSG00000265750.1 |
Gefitinib |
Brain lower grade glioma |
0.036732219 |
Resistant |
| ENSG00000265912.1 |
Gefitinib |
Brain lower grade glioma |
0.038459429 |
Resistant |
| ENSG00000266744.1 |
Gefitinib |
Brain lower grade glioma |
0.02221415 |
Resistant |
| ENSG00000267325.1 |
Gefitinib |
Brain lower grade glioma |
0.02404289 |
Resistant |
| ENSG00000272049.1 |
Gefitinib |
Brain lower grade glioma |
0.038629301 |
Resistant |
| ENSG00000272091.1 |
Gefitinib |
Brain lower grade glioma |
0.03030542 |
Resistant |
| ENSG00000272129.1 |
Gefitinib |
Brain lower grade glioma |
0.01317437 |
Resistant |
| ENSG00000272420.1 |
Gefitinib |
Brain lower grade glioma |
0.049369428 |
Resistant |
| ENSG00000272459.1 |
Gefitinib |
Brain lower grade glioma |
0.04698324 |
Resistant |
| ENSG00000272512.1 |
Gefitinib |
Brain lower grade glioma |
0.047989121 |
Resistant |
| ENSG00000272810.1 |
Gefitinib |
Brain lower grade glioma |
0.034160878 |
Resistant |
| ENSG00000272933.1 |
Gefitinib |
Brain lower grade glioma |
0.024925925 |
Resistant |
| ENSG00000273365.1 |
Gefitinib |
Brain lower grade glioma |
0.023614681 |
Resistant |
| ENSG00000157152.12 |
Gefitinib |
Lung squamous cell carcinoma |
0.020621693 |
Resistant |
| ENSG00000174403.11 |
Gefitinib |
Lung squamous cell carcinoma |
0.033965357 |
Resistant |
| ENSG00000180458.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.032702078 |
Resistant |
| ENSG00000185904.7 |
Gefitinib |
Lung squamous cell carcinoma |
0.024229228 |
Resistant |
| ENSG00000196960.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.019536941 |
Resistant |
| ENSG00000197558.7 |
Gefitinib |
Lung squamous cell carcinoma |
0.033531744 |
Resistant |
| ENSG00000203987.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.044118821 |
Resistant |
| ENSG00000204241.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.006505465 |
Resistant |
| ENSG00000204625.6 |
Gefitinib |
Lung squamous cell carcinoma |
0.017263946 |
Resistant |
| ENSG00000204815.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.016932273 |
Resistant |
| ENSG00000206417.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.002279677 |
Resistant |
| ENSG00000214955.5 |
Gefitinib |
Lung squamous cell carcinoma |
0.026351389 |
Resistant |
| ENSG00000223561.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.030364117 |
Resistant |
| ENSG00000223764.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.007547426 |
Resistant |
| ENSG00000223770.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.046140314 |
Resistant |
| ENSG00000223884.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029146456 |
Resistant |
| ENSG00000224142.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.039466444 |
Resistant |
| ENSG00000224363.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.036629055 |
Resistant |
| ENSG00000224655.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007447574 |
Resistant |
| ENSG00000224713.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.047005543 |
Resistant |
| ENSG00000225127.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.040481573 |
Resistant |
| ENSG00000225152.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019257287 |
Resistant |
| ENSG00000225235.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025140602 |
Resistant |
| ENSG00000225439.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.031927902 |
Resistant |
| ENSG00000225620.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041849128 |
Resistant |
| ENSG00000225891.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024668378 |
Resistant |
| ENSG00000225929.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.049175057 |
Resistant |
| ENSG00000225930.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.033056386 |
Resistant |
| ENSG00000225953.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.042966959 |
Resistant |
| ENSG00000226711.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.018066887 |
Resistant |
| ENSG00000226953.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.047043059 |
Resistant |
| ENSG00000227248.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.023921947 |
Resistant |
| ENSG00000227285.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.008534494 |
Resistant |
| ENSG00000227432.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024792381 |
Resistant |
| ENSG00000227438.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.02454969 |
Resistant |
| ENSG00000227603.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00281263 |
Resistant |
| ENSG00000228203.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.039016876 |
Resistant |
| ENSG00000228527.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.037348042 |
Resistant |
| ENSG00000228577.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034297732 |
Resistant |
| ENSG00000228643.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.036622791 |
Resistant |
| ENSG00000228692.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.028248342 |
Resistant |
| ENSG00000228794.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.015988737 |
Resistant |
| ENSG00000229400.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.03961131 |
Resistant |
| ENSG00000229536.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040465796 |
Resistant |
| ENSG00000229582.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.013997536 |
Resistant |
| ENSG00000229645.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.034313649 |
Resistant |
| ENSG00000230074.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.009034539 |
Resistant |
| ENSG00000230090.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041588485 |
Resistant |
| ENSG00000230239.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.048043339 |
Resistant |
| ENSG00000230461.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.03399593 |
Resistant |
| ENSG00000230552.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.020934632 |
Resistant |
| ENSG00000230699.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.021355278 |
Resistant |
| ENSG00000231128.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.049189346 |
Resistant |
| ENSG00000231367.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041827663 |
Resistant |
| ENSG00000231481.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012412298 |
Resistant |
| ENSG00000231527.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.042572552 |
Resistant |
| ENSG00000231728.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.008075468 |
Resistant |
| ENSG00000232224.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.023029445 |
Resistant |
| ENSG00000232611.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.004959737 |
Resistant |
| ENSG00000232784.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047253184 |
Resistant |
| ENSG00000232977.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.037494635 |
Resistant |
| ENSG00000233255.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.026972022 |
Resistant |
| ENSG00000233590.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012545124 |
Resistant |
| ENSG00000233757.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.049880835 |
Resistant |
| ENSG00000233844.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031496399 |
Resistant |
| ENSG00000233864.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.02635355 |
Resistant |
| ENSG00000233885.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.036166075 |
Resistant |
| ENSG00000234156.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031243893 |
Resistant |
| ENSG00000234215.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.032931383 |
Resistant |
| ENSG00000234336.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.01446683 |
Resistant |
| ENSG00000234428.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.036247349 |
Resistant |
| ENSG00000235033.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.026717176 |
Resistant |
| ENSG00000235072.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045047802 |
Resistant |
| ENSG00000235121.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018323818 |
Resistant |
| ENSG00000235185.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.037283495 |
Resistant |
| ENSG00000235652.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.042724737 |
Resistant |
| ENSG00000235760.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.027771639 |
Resistant |
| ENSG00000236390.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.006363681 |
Resistant |
| ENSG00000236451.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.04024039 |
Resistant |
| ENSG00000236467.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.032959997 |
Resistant |
| ENSG00000236537.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043309692 |
Resistant |
| ENSG00000236778.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.036867281 |
Resistant |
| ENSG00000236799.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.027464266 |
Resistant |
| ENSG00000236983.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045417054 |
Resistant |
| ENSG00000237187.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.047004862 |
Resistant |
| ENSG00000237336.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047453164 |
Resistant |
| ENSG00000237424.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034046931 |
Resistant |
| ENSG00000239377.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034486518 |
Resistant |
| ENSG00000239774.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025057614 |
Resistant |
| ENSG00000240553.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035667909 |
Resistant |
| ENSG00000241180.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028526703 |
Resistant |
| ENSG00000241570.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.039343377 |
Resistant |
| ENSG00000242048.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.027348566 |
Resistant |
| ENSG00000242540.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.021158517 |
Resistant |
| ENSG00000242686.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.026288286 |
Resistant |
| ENSG00000243193.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.039597414 |
Resistant |
| ENSG00000243389.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.037074486 |
Resistant |
| ENSG00000244040.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043011028 |
Resistant |
| ENSG00000245857.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.049512972 |
Resistant |
| ENSG00000246528.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.049292452 |
Resistant |
| ENSG00000246763.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.014368472 |
Resistant |
| ENSG00000246859.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.014372029 |
Resistant |
| ENSG00000248092.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.020634642 |
Resistant |
| ENSG00000248103.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034610771 |
Resistant |
| ENSG00000248228.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045830771 |
Resistant |
| ENSG00000248371.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025183344 |
Resistant |
| ENSG00000248445.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.039059277 |
Resistant |
| ENSG00000248479.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.049488678 |
Resistant |
| ENSG00000248682.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028826613 |
Resistant |
| ENSG00000248714.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.045866016 |
Resistant |
| ENSG00000248774.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025065748 |
Resistant |
| ENSG00000248890.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.033473061 |
Resistant |
| ENSG00000248949.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.044170526 |
Resistant |
| ENSG00000249035.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.017669135 |
Resistant |
| ENSG00000249167.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.039324196 |
Resistant |
| ENSG00000249610.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.046117639 |
Resistant |
| ENSG00000249650.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019585539 |
Resistant |
| ENSG00000249684.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.048908354 |
Resistant |
| ENSG00000249781.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.039204562 |
Resistant |
| ENSG00000250101.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.03917145 |
Resistant |
| ENSG00000250131.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.046527757 |
Resistant |
| ENSG00000250948.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.009620394 |
Resistant |
| ENSG00000251301.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.029614563 |
Resistant |
| ENSG00000251379.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.039562717 |
Resistant |
| ENSG00000251613.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.014189635 |
Resistant |
| ENSG00000253553.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034016465 |
Resistant |
| ENSG00000253636.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001604639 |
Resistant |
| ENSG00000253925.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.033773663 |
Resistant |
| ENSG00000253983.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.022572902 |
Resistant |
| ENSG00000254251.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.036959132 |
Resistant |
| ENSG00000254288.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019386378 |
Resistant |
| ENSG00000254486.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.02517605 |
Resistant |
| ENSG00000254533.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032239448 |
Resistant |
| ENSG00000254981.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029098335 |
Resistant |
| ENSG00000255201.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.000888756 |
Resistant |
| ENSG00000255248.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.020970546 |
Resistant |
| ENSG00000255372.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.033693818 |
Resistant |
| ENSG00000255382.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.03751197 |
Resistant |
| ENSG00000255474.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047322056 |
Resistant |
| ENSG00000255670.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040001675 |
Resistant |
| ENSG00000256084.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022333583 |
Resistant |
| ENSG00000257346.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.016122744 |
Resistant |
| ENSG00000257613.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012621631 |
Resistant |
| ENSG00000257910.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035910952 |
Resistant |
| ENSG00000258308.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.015387421 |
Resistant |
| ENSG00000258337.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04352801 |
Resistant |
| ENSG00000259327.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.030026095 |
Resistant |
| ENSG00000259448.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.028687814 |
Resistant |
| ENSG00000259772.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.047596337 |
Resistant |
| ENSG00000259843.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.01538204 |
Resistant |
| ENSG00000259969.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019478089 |
Resistant |
| ENSG00000260035.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.015656338 |
Resistant |
| ENSG00000260077.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012929533 |
Resistant |
| ENSG00000260123.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047605607 |
Resistant |
| ENSG00000260132.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031179521 |
Resistant |
| ENSG00000260316.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028998174 |
Resistant |
| ENSG00000260655.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002903988 |
Resistant |
| ENSG00000260831.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.023147961 |
Resistant |
| ENSG00000260920.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040024067 |
Resistant |
| ENSG00000260922.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.01247533 |
Resistant |
| ENSG00000260931.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002613247 |
Resistant |
| ENSG00000260948.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.026908206 |
Resistant |
| ENSG00000261003.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025605456 |
Resistant |
| ENSG00000261037.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.033609232 |
Resistant |
| ENSG00000261168.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.004902116 |
Resistant |
| ENSG00000261396.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032998795 |
Resistant |
| ENSG00000261646.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.044443918 |
Resistant |
| ENSG00000261790.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.044588255 |
Resistant |
| ENSG00000261827.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012812786 |
Resistant |
| ENSG00000262179.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.039118601 |
Resistant |
| ENSG00000262319.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040587563 |
Resistant |
| ENSG00000262877.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.013512948 |
Resistant |
| ENSG00000263015.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.0198353 |
Resistant |
| ENSG00000264083.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00643879 |
Resistant |
| ENSG00000265113.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.014239634 |
Resistant |
| ENSG00000265542.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.020910913 |
Resistant |
| ENSG00000266368.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.038441941 |
Resistant |
| ENSG00000266446.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028372768 |
Resistant |
| ENSG00000266912.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.042028248 |
Resistant |
| ENSG00000266930.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.04953845 |
Resistant |
| ENSG00000266933.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022651253 |
Resistant |
| ENSG00000266935.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.01908917 |
Resistant |
| ENSG00000266965.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04123691 |
Resistant |
| ENSG00000266999.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021843042 |
Resistant |
| ENSG00000267040.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.048608935 |
Resistant |
| ENSG00000267065.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.01464323 |
Resistant |
| ENSG00000267136.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024180863 |
Resistant |
| ENSG00000267161.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.037578324 |
Resistant |
| ENSG00000267289.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018910797 |
Resistant |
| ENSG00000267366.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040553643 |
Resistant |
| ENSG00000267702.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021723739 |
Resistant |
| ENSG00000267785.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041299428 |
Resistant |
| ENSG00000267787.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.03676535 |
Resistant |
| ENSG00000269892.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.013214968 |
Resistant |
| ENSG00000269934.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.023385805 |
Resistant |
| ENSG00000269950.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035270561 |
Resistant |
| ENSG00000270052.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043822679 |
Resistant |
| ENSG00000270104.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.049007741 |
Resistant |
| ENSG00000270173.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019688693 |
Resistant |
| ENSG00000270178.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.044324318 |
Resistant |
| ENSG00000270189.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025256111 |
Resistant |
| ENSG00000270223.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.009032464 |
Resistant |
| ENSG00000271172.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019980642 |
Resistant |
| ENSG00000271420.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028515667 |
Resistant |
| ENSG00000271579.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.014630878 |
Resistant |
| ENSG00000271716.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.011656421 |
Resistant |
| ENSG00000271845.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007530765 |
Resistant |
| ENSG00000271871.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040851936 |
Resistant |
| ENSG00000271948.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00798412 |
Resistant |
| ENSG00000272002.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001342897 |
Resistant |
| ENSG00000272048.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.030703787 |
Resistant |
| ENSG00000272130.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.011120925 |
Resistant |
| ENSG00000272217.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.005655534 |
Resistant |
| ENSG00000272334.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007937457 |
Resistant |
| ENSG00000272438.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043546962 |
Resistant |
| ENSG00000272452.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031909287 |
Resistant |
| ENSG00000272541.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029374994 |
Resistant |
| ENSG00000272657.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.010962475 |
Resistant |
| ENSG00000272699.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.046249572 |
Resistant |
| ENSG00000272733.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032828107 |
Resistant |
| ENSG00000272746.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021623216 |
Resistant |
| ENSG00000272798.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.049672319 |
Resistant |
| ENSG00000272912.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032643809 |
Resistant |
| ENSG00000272983.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029815309 |
Resistant |
| ENSG00000273081.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.049436703 |
Resistant |
| ENSG00000273091.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024768905 |
Resistant |
| ENSG00000273104.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.009456256 |
Resistant |
| ENSG00000273253.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.01947769 |
Resistant |
| ENSG00000273483.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012396 |
Resistant |
| ENSG00000178977.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03743342 |
Resistant |
| ENSG00000186594.8 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030888432 |
Resistant |
| ENSG00000188660.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032526541 |
Resistant |
| ENSG00000204815.4 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032713016 |
Resistant |
| ENSG00000205611.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005077534 |
Resistant |
| ENSG00000215241.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007677093 |
Resistant |
| ENSG00000226756.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012855293 |
Resistant |
| ENSG00000226891.2 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046302799 |
Resistant |
| ENSG00000229180.4 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043591141 |
Resistant |
| ENSG00000229989.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031335858 |
Resistant |
| ENSG00000230487.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028215095 |
Resistant |
| ENSG00000231242.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0049389 |
Resistant |
| ENSG00000231616.4 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032067542 |
Resistant |
| ENSG00000232151.5 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019143296 |
Resistant |
| ENSG00000232729.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006944873 |
Resistant |
| ENSG00000232973.7 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003530326 |
Resistant |
| ENSG00000234185.2 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03120492 |
Resistant |
| ENSG00000234459.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041669668 |
Resistant |
| ENSG00000234899.5 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021186546 |
Resistant |
| ENSG00000234998.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038679409 |
Resistant |
| ENSG00000235703.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033447588 |
Resistant |
| ENSG00000236337.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02084517 |
Resistant |
| ENSG00000236772.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035201624 |
Resistant |
| ENSG00000237998.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007455118 |
Resistant |
| ENSG00000242553.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040594588 |
Resistant |
| ENSG00000244879.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018034755 |
Resistant |
| ENSG00000245573.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00995184 |
Resistant |
| ENSG00000246339.4 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023590072 |
Resistant |
| ENSG00000246422.2 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026951798 |
Resistant |
| ENSG00000246640.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029116965 |
Resistant |
| ENSG00000249131.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043547923 |
Resistant |
| ENSG00000251330.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007254359 |
Resistant |
| ENSG00000251615.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00742242 |
Resistant |
| ENSG00000254539.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029280245 |
Resistant |
| ENSG00000256603.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034722212 |
Resistant |
| ENSG00000256670.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009238383 |
Resistant |
| ENSG00000257621.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026163707 |
Resistant |
| ENSG00000258682.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011948459 |
Resistant |
| ENSG00000259548.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031672748 |
Resistant |
| ENSG00000260011.2 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045780348 |
Resistant |
| ENSG00000260038.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018873283 |
Resistant |
| ENSG00000260051.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027809764 |
Resistant |
| ENSG00000260635.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032128161 |
Resistant |
| ENSG00000260986.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041798566 |
Resistant |
| ENSG00000260988.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008763141 |
Resistant |
| ENSG00000261879.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012573077 |
Resistant |
| ENSG00000267219.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048241438 |
Resistant |
| ENSG00000268947.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032255412 |
Resistant |
| ENSG00000269894.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025871517 |
Resistant |
| ENSG00000269956.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01887522 |
Resistant |
| ENSG00000270130.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010493083 |
Resistant |
| ENSG00000270223.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000944623 |
Resistant |
| ENSG00000270720.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040160289 |
Resistant |
| ENSG00000271032.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021384395 |
Resistant |
| ENSG00000271327.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009091697 |
Resistant |
| ENSG00000272072.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039606023 |
Resistant |
| ENSG00000272091.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009633528 |
Resistant |
| ENSG00000272320.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031462741 |
Resistant |
| ENSG00000272604.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020425877 |
Resistant |
| ENSG00000272695.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002447864 |
Resistant |
| ENSG00000272864.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035022866 |
Resistant |
| ENSG00000273131.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04097622 |
Resistant |
| ENSG00000273271.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030099712 |
Resistant |
| ENSG00000273487.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034456801 |
Resistant |
| ENSG00000204929.7 |
Gefitinib |
Pancreatic adenocarcinoma |
0.044306333 |
Resistant |
| ENSG00000226890.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.027666453 |
Resistant |
| ENSG00000227053.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.039216093 |
Resistant |
| ENSG00000227630.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.017340827 |
Resistant |
| ENSG00000250267.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.008724977 |
Resistant |
| ENSG00000253315.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.011828918 |
Resistant |
| ENSG00000261420.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.017057446 |
Resistant |
| ENSG00000264647.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.000804959 |
Resistant |
| ENSG00000266498.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.043312472 |
Resistant |
| ENSG00000266936.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.022073987 |
Resistant |
| ENSG00000272375.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.0359625 |
Resistant |
| ENSG00000272832.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.022247667 |
Resistant |
| ENSG00000273487.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.009282712 |
Resistant |
| ENSG00000203709.5 |
Gefitinib |
Sarcoma |
0.041228277 |
Resistant |
| ENSG00000227518.2 |
Gefitinib |
Sarcoma |
0.038187489 |
Resistant |
| ENSG00000228723.2 |
Gefitinib |
Sarcoma |
0.039829331 |
Resistant |
| ENSG00000229267.2 |
Gefitinib |
Sarcoma |
0.017251233 |
Resistant |
| ENSG00000229915.1 |
Gefitinib |
Sarcoma |
0.022464771 |
Resistant |
| ENSG00000230850.3 |
Gefitinib |
Sarcoma |
0.034029274 |
Resistant |
| ENSG00000233061.1 |
Gefitinib |
Sarcoma |
0.035741658 |
Resistant |
| ENSG00000233926.1 |
Gefitinib |
Sarcoma |
0.048107425 |
Resistant |
| ENSG00000235724.4 |
Gefitinib |
Sarcoma |
0.009902665 |
Resistant |
| ENSG00000237978.1 |
Gefitinib |
Sarcoma |
0.044978883 |
Resistant |
| ENSG00000239335.4 |
Gefitinib |
Sarcoma |
0.049266642 |
Resistant |
| ENSG00000243055.1 |
Gefitinib |
Sarcoma |
0.003136607 |
Resistant |
| ENSG00000243433.1 |
Gefitinib |
Sarcoma |
0.00158155 |
Resistant |
| ENSG00000245937.3 |
Gefitinib |
Sarcoma |
0.042035036 |
Resistant |
| ENSG00000254109.1 |
Gefitinib |
Sarcoma |
0.033838777 |
Resistant |
| ENSG00000254538.1 |
Gefitinib |
Sarcoma |
0.011694248 |
Resistant |
| ENSG00000256433.1 |
Gefitinib |
Sarcoma |
0.019653735 |
Resistant |
| ENSG00000257176.1 |
Gefitinib |
Sarcoma |
0.039678046 |
Resistant |
| ENSG00000257507.1 |
Gefitinib |
Sarcoma |
0.032961765 |
Resistant |
| ENSG00000257557.1 |
Gefitinib |
Sarcoma |
0.042567229 |
Resistant |
| ENSG00000259158.1 |
Gefitinib |
Sarcoma |
0.045019841 |
Resistant |
| ENSG00000259520.1 |
Gefitinib |
Sarcoma |
0.04086112 |
Resistant |
| ENSG00000260742.1 |
Gefitinib |
Sarcoma |
0.016465218 |
Resistant |
| ENSG00000261101.1 |
Gefitinib |
Sarcoma |
0.015470963 |
Resistant |
| ENSG00000261253.1 |
Gefitinib |
Sarcoma |
0.005379468 |
Resistant |
| ENSG00000262115.1 |
Gefitinib |
Sarcoma |
0.016364268 |
Resistant |
| ENSG00000263443.1 |
Gefitinib |
Sarcoma |
0.023661177 |
Resistant |
| ENSG00000263718.2 |
Gefitinib |
Sarcoma |
0.040972943 |
Resistant |
| ENSG00000266903.1 |
Gefitinib |
Sarcoma |
0.046335332 |
Resistant |
| ENSG00000269946.1 |
Gefitinib |
Sarcoma |
0.006290043 |
Resistant |
| ENSG00000272312.1 |
Gefitinib |
Sarcoma |
0.00091329 |
Resistant |
| ENSG00000272341.1 |
Gefitinib |
Sarcoma |
0.00670828 |
Resistant |
| ENSG00000272346.1 |
Gefitinib |
Sarcoma |
0.026048531 |
Resistant |
| ENSG00000272489.1 |
Gefitinib |
Sarcoma |
0.037030331 |
Resistant |
| ENSG00000272707.1 |
Gefitinib |
Sarcoma |
0.003182728 |
Resistant |
| ENSG00000272761.1 |
Gefitinib |
Sarcoma |
0.042466038 |
Resistant |
| ENSG00000273402.1 |
Gefitinib |
Sarcoma |
0.008701 |
Resistant |
| ENSG00000223813.2 |
Gefitinib |
Skin cutaneous melanoma |
0.036462518 |
Resistant |
| ENSG00000224934.2 |
Gefitinib |
Skin cutaneous melanoma |
0.022362906 |
Resistant |
| ENSG00000225084.1 |
Gefitinib |
Skin cutaneous melanoma |
0.043699391 |
Resistant |
| ENSG00000227518.2 |
Gefitinib |
Skin cutaneous melanoma |
0.038361846 |
Resistant |
| ENSG00000228763.1 |
Gefitinib |
Skin cutaneous melanoma |
0.000725979 |
Resistant |
| ENSG00000229109.1 |
Gefitinib |
Skin cutaneous melanoma |
0.030564498 |
Resistant |
| ENSG00000234449.2 |
Gefitinib |
Skin cutaneous melanoma |
0.038927174 |
Resistant |
| ENSG00000235262.1 |
Gefitinib |
Skin cutaneous melanoma |
0.004818453 |
Resistant |
| ENSG00000236051.2 |
Gefitinib |
Skin cutaneous melanoma |
0.003531152 |
Resistant |
| ENSG00000243766.3 |
Gefitinib |
Skin cutaneous melanoma |
0.000233071 |
Resistant |
| ENSG00000249870.1 |
Gefitinib |
Skin cutaneous melanoma |
0.024352984 |
Resistant |
| ENSG00000253197.1 |
Gefitinib |
Skin cutaneous melanoma |
0.004203825 |
Resistant |
| ENSG00000253284.2 |
Gefitinib |
Skin cutaneous melanoma |
0.032955449 |
Resistant |
| ENSG00000254208.1 |
Gefitinib |
Skin cutaneous melanoma |
0.001402871 |
Resistant |
| ENSG00000254973.1 |
Gefitinib |
Skin cutaneous melanoma |
0.022702103 |
Resistant |
| ENSG00000255474.1 |
Gefitinib |
Skin cutaneous melanoma |
0.022790556 |
Resistant |
| ENSG00000257027.1 |
Gefitinib |
Skin cutaneous melanoma |
0.018418481 |
Resistant |
| ENSG00000259437.1 |
Gefitinib |
Skin cutaneous melanoma |
0.037929505 |
Resistant |
| ENSG00000259783.1 |
Gefitinib |
Skin cutaneous melanoma |
0.028171532 |
Resistant |
| ENSG00000262686.1 |
Gefitinib |
Skin cutaneous melanoma |
0.037437013 |
Resistant |
| ENSG00000265142.2 |
Gefitinib |
Skin cutaneous melanoma |
0.040509202 |
Resistant |
| ENSG00000265206.2 |
Gefitinib |
Skin cutaneous melanoma |
0.037370906 |
Resistant |
| ENSG00000265487.1 |
Gefitinib |
Skin cutaneous melanoma |
0.002211318 |
Resistant |
| ENSG00000267280.1 |
Gefitinib |
Skin cutaneous melanoma |
0.028300236 |
Resistant |
| ENSG00000267344.1 |
Gefitinib |
Skin cutaneous melanoma |
0.013909287 |
Resistant |
| ENSG00000267546.2 |
Gefitinib |
Skin cutaneous melanoma |
0.01407463 |
Resistant |
| ENSG00000268605.1 |
Gefitinib |
Skin cutaneous melanoma |
0.0071486 |
Resistant |
| ENSG00000269172.1 |
Gefitinib |
Skin cutaneous melanoma |
0.032561808 |
Resistant |
| ENSG00000270010.1 |
Gefitinib |
Skin cutaneous melanoma |
0.026384753 |
Resistant |
| ENSG00000270036.1 |
Gefitinib |
Skin cutaneous melanoma |
0.041205824 |
Resistant |
| ENSG00000270223.1 |
Gefitinib |
Skin cutaneous melanoma |
0.005163081 |
Resistant |
| ENSG00000271856.1 |
Gefitinib |
Skin cutaneous melanoma |
0.003340862 |
Resistant |
| ENSG00000272211.1 |
Gefitinib |
Skin cutaneous melanoma |
0.046650004 |
Resistant |
| ENSG00000272216.1 |
Gefitinib |
Skin cutaneous melanoma |
0.021858596 |
Resistant |
| ENSG00000272516.1 |
Gefitinib |
Skin cutaneous melanoma |
0.037476622 |
Resistant |
| ENSG00000272672.1 |
Gefitinib |
Skin cutaneous melanoma |
0.032382659 |
Resistant |
| ENSG00000273381.1 |
Gefitinib |
Skin cutaneous melanoma |
0.004381947 |
Resistant |
| ENSG00000163597.10 |
Gefitinib |
Stomach adenocarcinoma |
0.015798538 |
Resistant |
| ENSG00000177133.6 |
Gefitinib |
Stomach adenocarcinoma |
0.022482672 |
Resistant |
| ENSG00000224745.1 |
Gefitinib |
Stomach adenocarcinoma |
0.022365091 |
Resistant |
| ENSG00000224888.3 |
Gefitinib |
Stomach adenocarcinoma |
0.049058385 |
Resistant |
| ENSG00000225037.1 |
Gefitinib |
Stomach adenocarcinoma |
0.02335571 |
Resistant |
| ENSG00000225213.2 |
Gefitinib |
Stomach adenocarcinoma |
0.0078376 |
Resistant |
| ENSG00000225439.2 |
Gefitinib |
Stomach adenocarcinoma |
0.015890484 |
Resistant |
| ENSG00000227245.1 |
Gefitinib |
Stomach adenocarcinoma |
0.019105377 |
Resistant |
| ENSG00000228137.1 |
Gefitinib |
Stomach adenocarcinoma |
0.004806519 |
Resistant |
| ENSG00000228604.3 |
Gefitinib |
Stomach adenocarcinoma |
0.048583661 |
Resistant |
| ENSG00000228838.1 |
Gefitinib |
Stomach adenocarcinoma |
0.037577658 |
Resistant |
| ENSG00000229989.3 |
Gefitinib |
Stomach adenocarcinoma |
0.004323054 |
Resistant |
| ENSG00000234546.2 |
Gefitinib |
Stomach adenocarcinoma |
0.030022915 |
Resistant |
| ENSG00000235119.1 |
Gefitinib |
Stomach adenocarcinoma |
0.036259084 |
Resistant |
| ENSG00000236991.2 |
Gefitinib |
Stomach adenocarcinoma |
0.047030089 |
Resistant |
| ENSG00000245750.3 |
Gefitinib |
Stomach adenocarcinoma |
0.034173641 |
Resistant |
| ENSG00000246982.2 |
Gefitinib |
Stomach adenocarcinoma |
0.018006849 |
Resistant |
| ENSG00000254907.1 |
Gefitinib |
Stomach adenocarcinoma |
0.023758838 |
Resistant |
| ENSG00000255165.1 |
Gefitinib |
Stomach adenocarcinoma |
0.014396442 |
Resistant |
| ENSG00000258682.1 |
Gefitinib |
Stomach adenocarcinoma |
0.034499687 |
Resistant |
| ENSG00000258725.1 |
Gefitinib |
Stomach adenocarcinoma |
0.041516611 |
Resistant |
| ENSG00000258798.1 |
Gefitinib |
Stomach adenocarcinoma |
0.002312449 |
Resistant |
| ENSG00000259212.1 |
Gefitinib |
Stomach adenocarcinoma |
0.010382477 |
Resistant |
| ENSG00000259540.1 |
Gefitinib |
Stomach adenocarcinoma |
0.009197763 |
Resistant |
| ENSG00000260447.1 |
Gefitinib |
Stomach adenocarcinoma |
0.032778731 |
Resistant |
| ENSG00000260743.1 |
Gefitinib |
Stomach adenocarcinoma |
0.027165976 |
Resistant |
| ENSG00000261770.1 |
Gefitinib |
Stomach adenocarcinoma |
0.026360832 |
Resistant |
| ENSG00000261799.1 |
Gefitinib |
Stomach adenocarcinoma |
0.028165335 |
Resistant |
| ENSG00000262222.1 |
Gefitinib |
Stomach adenocarcinoma |
0.03210449 |
Resistant |
| ENSG00000262312.1 |
Gefitinib |
Stomach adenocarcinoma |
0.019503145 |
Resistant |
| ENSG00000263080.1 |
Gefitinib |
Stomach adenocarcinoma |
0.047444788 |
Resistant |
| ENSG00000263257.1 |
Gefitinib |
Stomach adenocarcinoma |
0.040399 |
Resistant |
| ENSG00000264112.1 |
Gefitinib |
Stomach adenocarcinoma |
0.014900552 |
Resistant |
| ENSG00000265349.1 |
Gefitinib |
Stomach adenocarcinoma |
0.047306745 |
Resistant |
| ENSG00000265791.1 |
Gefitinib |
Stomach adenocarcinoma |
0.030217858 |
Resistant |
| ENSG00000267025.1 |
Gefitinib |
Stomach adenocarcinoma |
0.021129924 |
Resistant |
| ENSG00000267141.1 |
Gefitinib |
Stomach adenocarcinoma |
0.033855949 |
Resistant |
| ENSG00000267197.1 |
Gefitinib |
Stomach adenocarcinoma |
0.024878014 |
Resistant |
| ENSG00000267249.1 |
Gefitinib |
Stomach adenocarcinoma |
0.028591764 |
Resistant |
| ENSG00000267798.1 |
Gefitinib |
Stomach adenocarcinoma |
0.023761936 |
Resistant |
| ENSG00000269148.1 |
Gefitinib |
Stomach adenocarcinoma |
0.013052811 |
Resistant |
| ENSG00000272023.1 |
Gefitinib |
Stomach adenocarcinoma |
0.049035881 |
Resistant |
| ENSG00000272690.1 |
Gefitinib |
Stomach adenocarcinoma |
0.007685464 |
Resistant |
| ENSG00000272970.1 |
Gefitinib |
Stomach adenocarcinoma |
0.032715743 |
Resistant |
| ENSG00000273116.1 |
Gefitinib |
Stomach adenocarcinoma |
0.024779616 |
Resistant |
| ENSG00000172965.10 |
Gefitinib |
Thyroid carcinoma |
0.029348304 |
Resistant |
| ENSG00000223725.2 |
Gefitinib |
Thyroid carcinoma |
0.023749307 |
Resistant |
| ENSG00000227071.1 |
Gefitinib |
Thyroid carcinoma |
0.006789081 |
Resistant |
| ENSG00000228536.1 |
Gefitinib |
Thyroid carcinoma |
0.022358114 |
Resistant |
| ENSG00000229647.1 |
Gefitinib |
Thyroid carcinoma |
0.0487577 |
Resistant |
| ENSG00000230082.1 |
Gefitinib |
Thyroid carcinoma |
0.024542368 |
Resistant |
| ENSG00000232633.3 |
Gefitinib |
Thyroid carcinoma |
0.03971239 |
Resistant |
| ENSG00000236540.3 |
Gefitinib |
Thyroid carcinoma |
0.000853487 |
Resistant |
| ENSG00000236581.4 |
Gefitinib |
Thyroid carcinoma |
0.016819141 |
Resistant |
| ENSG00000238280.1 |
Gefitinib |
Thyroid carcinoma |
0.028103283 |
Resistant |
| ENSG00000241472.2 |
Gefitinib |
Thyroid carcinoma |
0.010842887 |
Resistant |
| ENSG00000254639.1 |
Gefitinib |
Thyroid carcinoma |
0.031827352 |
Resistant |
| ENSG00000256789.1 |
Gefitinib |
Thyroid carcinoma |
0.015332097 |
Resistant |
| ENSG00000258535.1 |
Gefitinib |
Thyroid carcinoma |
0.035713681 |
Resistant |
| ENSG00000259070.1 |
Gefitinib |
Thyroid carcinoma |
0.028782491 |
Resistant |
| ENSG00000259735.1 |
Gefitinib |
Thyroid carcinoma |
0.005328396 |
Resistant |
| ENSG00000259901.1 |
Gefitinib |
Thyroid carcinoma |
0.024034981 |
Resistant |
| ENSG00000262265.1 |
Gefitinib |
Thyroid carcinoma |
0.035234359 |
Resistant |
| ENSG00000263731.1 |
Gefitinib |
Thyroid carcinoma |
0.004025768 |
Resistant |
| ENSG00000263859.1 |
Gefitinib |
Thyroid carcinoma |
0.038950649 |
Resistant |
| ENSG00000268613.1 |
Gefitinib |
Thyroid carcinoma |
0.017251869 |
Resistant |
| ENSG00000269646.1 |
Gefitinib |
Thyroid carcinoma |
0.047866191 |
Resistant |
| ENSG00000269906.1 |
Gefitinib |
Thyroid carcinoma |
0.039211927 |
Resistant |
| ENSG00000273001.1 |
Gefitinib |
Thyroid carcinoma |
0.03703479 |
Resistant |
| ENSG00000178977.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.0352399 |
Sensitive |
| ENSG00000203441.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.029468122 |
Sensitive |
| ENSG00000213468.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.034304919 |
Sensitive |
| ENSG00000215159.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.011981687 |
Sensitive |
| ENSG00000223734.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.037682254 |
Sensitive |
| ENSG00000224818.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.014729782 |
Sensitive |
| ENSG00000225087.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.004008416 |
Sensitive |
| ENSG00000225945.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.028691327 |
Sensitive |
| ENSG00000226287.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.023740122 |
Sensitive |
| ENSG00000226328.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.018283883 |
Sensitive |
| ENSG00000226920.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.028680095 |
Sensitive |
| ENSG00000227172.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.025907042 |
Sensitive |
| ENSG00000227210.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.03645142 |
Sensitive |
| ENSG00000227674.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.027119681 |
Sensitive |
| ENSG00000228150.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.013320995 |
Sensitive |
| ENSG00000228701.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.048444164 |
Sensitive |
| ENSG00000229401.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.01688663 |
Sensitive |
| ENSG00000229688.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.000213931 |
Sensitive |
| ENSG00000230054.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.040711666 |
Sensitive |
| ENSG00000231551.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.007400384 |
Sensitive |
| ENSG00000231734.4 |
Gefitinib |
Bladder urothelial carcinoma |
0.030443216 |
Sensitive |
| ENSG00000231966.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.003943049 |
Sensitive |
| ENSG00000232298.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.004008315 |
Sensitive |
| ENSG00000233008.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.037891529 |
Sensitive |
| ENSG00000234571.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.043420527 |
Sensitive |
| ENSG00000235831.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.000505432 |
Sensitive |
| ENSG00000236212.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.046250777 |
Sensitive |
| ENSG00000236641.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.017886098 |
Sensitive |
| ENSG00000237594.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.046151899 |
Sensitive |
| ENSG00000237609.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.047812654 |
Sensitive |
| ENSG00000237883.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.000248303 |
Sensitive |
| ENSG00000242569.3 |
Gefitinib |
Bladder urothelial carcinoma |
0.00716838 |
Sensitive |
| ENSG00000245729.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.027925734 |
Sensitive |
| ENSG00000246225.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.047345989 |
Sensitive |
| ENSG00000246740.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.03097149 |
Sensitive |
| ENSG00000246898.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.000598907 |
Sensitive |
| ENSG00000248238.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.001258706 |
Sensitive |
| ENSG00000250874.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.008107078 |
Sensitive |
| ENSG00000251129.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.043210027 |
Sensitive |
| ENSG00000251324.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.000576106 |
Sensitive |
| ENSG00000251611.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.00537367 |
Sensitive |
| ENSG00000253696.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.008122383 |
Sensitive |
| ENSG00000256196.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.023725123 |
Sensitive |
| ENSG00000258301.2 |
Gefitinib |
Bladder urothelial carcinoma |
0.025154473 |
Sensitive |
| ENSG00000259438.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.007854605 |
Sensitive |
| ENSG00000259673.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.010960697 |
Sensitive |
| ENSG00000259694.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.039980157 |
Sensitive |
| ENSG00000260954.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.015933385 |
Sensitive |
| ENSG00000261916.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.015581321 |
Sensitive |
| ENSG00000263050.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.00619202 |
Sensitive |
| ENSG00000263931.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.010587428 |
Sensitive |
| ENSG00000265478.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.037786862 |
Sensitive |
| ENSG00000265542.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.008757026 |
Sensitive |
| ENSG00000265702.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.04846194 |
Sensitive |
| ENSG00000266718.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.003321254 |
Sensitive |
| ENSG00000266824.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.028921663 |
Sensitive |
| ENSG00000267052.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.030910693 |
Sensitive |
| ENSG00000267284.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.023041672 |
Sensitive |
| ENSG00000267327.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.044284933 |
Sensitive |
| ENSG00000267729.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.015141838 |
Sensitive |
| ENSG00000267783.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.024204608 |
Sensitive |
| ENSG00000268266.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.002187584 |
Sensitive |
| ENSG00000269614.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.033525198 |
Sensitive |
| ENSG00000270265.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.00904375 |
Sensitive |
| ENSG00000270964.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.017299321 |
Sensitive |
| ENSG00000271826.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.020229951 |
Sensitive |
| ENSG00000272446.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.028280473 |
Sensitive |
| ENSG00000272556.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.014182399 |
Sensitive |
| ENSG00000272682.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.004954532 |
Sensitive |
| ENSG00000273084.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.035195927 |
Sensitive |
| ENSG00000273213.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.00339516 |
Sensitive |
| ENSG00000273230.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.00825559 |
Sensitive |
| ENSG00000273335.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.000248727 |
Sensitive |
| ENSG00000273341.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.005161998 |
Sensitive |
| ENSG00000273406.1 |
Gefitinib |
Bladder urothelial carcinoma |
0.007132199 |
Sensitive |
| ENSG00000177112.3 |
Gefitinib |
Breast invasive carcinoma |
0.04548649 |
Sensitive |
| ENSG00000180279.5 |
Gefitinib |
Breast invasive carcinoma |
0.035853115 |
Sensitive |
| ENSG00000189419.5 |
Gefitinib |
Breast invasive carcinoma |
0.033502906 |
Sensitive |
| ENSG00000203280.3 |
Gefitinib |
Breast invasive carcinoma |
0.006565275 |
Sensitive |
| ENSG00000204832.5 |
Gefitinib |
Breast invasive carcinoma |
0.012929993 |
Sensitive |
| ENSG00000214049.6 |
Gefitinib |
Breast invasive carcinoma |
0.036928416 |
Sensitive |
| ENSG00000214894.2 |
Gefitinib |
Breast invasive carcinoma |
0.039321504 |
Sensitive |
| ENSG00000215841.3 |
Gefitinib |
Breast invasive carcinoma |
0.000927459 |
Sensitive |
| ENSG00000223813.2 |
Gefitinib |
Breast invasive carcinoma |
0.00487351 |
Sensitive |
| ENSG00000223956.1 |
Gefitinib |
Breast invasive carcinoma |
0.044664285 |
Sensitive |
| ENSG00000224079.1 |
Gefitinib |
Breast invasive carcinoma |
0.021038469 |
Sensitive |
| ENSG00000225037.1 |
Gefitinib |
Breast invasive carcinoma |
0.040938466 |
Sensitive |
| ENSG00000225408.1 |
Gefitinib |
Breast invasive carcinoma |
0.026584073 |
Sensitive |
| ENSG00000225532.1 |
Gefitinib |
Breast invasive carcinoma |
0.013526605 |
Sensitive |
| ENSG00000225656.1 |
Gefitinib |
Breast invasive carcinoma |
0.039300133 |
Sensitive |
| ENSG00000225744.1 |
Gefitinib |
Breast invasive carcinoma |
0.042366405 |
Sensitive |
| ENSG00000226051.2 |
Gefitinib |
Breast invasive carcinoma |
0.014134461 |
Sensitive |
| ENSG00000226287.3 |
Gefitinib |
Breast invasive carcinoma |
0.001765066 |
Sensitive |
| ENSG00000226377.1 |
Gefitinib |
Breast invasive carcinoma |
0.044588966 |
Sensitive |
| ENSG00000227014.1 |
Gefitinib |
Breast invasive carcinoma |
0.031294554 |
Sensitive |
| ENSG00000227117.2 |
Gefitinib |
Breast invasive carcinoma |
0.018694212 |
Sensitive |
| ENSG00000227630.2 |
Gefitinib |
Breast invasive carcinoma |
0.045459662 |
Sensitive |
| ENSG00000228526.2 |
Gefitinib |
Breast invasive carcinoma |
0.046240613 |
Sensitive |
| ENSG00000228737.2 |
Gefitinib |
Breast invasive carcinoma |
0.037180216 |
Sensitive |
| ENSG00000228918.3 |
Gefitinib |
Breast invasive carcinoma |
0.044193335 |
Sensitive |
| ENSG00000229905.1 |
Gefitinib |
Breast invasive carcinoma |
0.033180365 |
Sensitive |
| ENSG00000229980.4 |
Gefitinib |
Breast invasive carcinoma |
0.021147766 |
Sensitive |
| ENSG00000229990.2 |
Gefitinib |
Breast invasive carcinoma |
0.028492265 |
Sensitive |
| ENSG00000230212.2 |
Gefitinib |
Breast invasive carcinoma |
0.043921339 |
Sensitive |
| ENSG00000230423.1 |
Gefitinib |
Breast invasive carcinoma |
0.029010249 |
Sensitive |
| ENSG00000230724.5 |
Gefitinib |
Breast invasive carcinoma |
0.021966676 |
Sensitive |
| ENSG00000231310.2 |
Gefitinib |
Breast invasive carcinoma |
0.04623957 |
Sensitive |
| ENSG00000231512.1 |
Gefitinib |
Breast invasive carcinoma |
0.011366284 |
Sensitive |
| ENSG00000231654.1 |
Gefitinib |
Breast invasive carcinoma |
0.024207668 |
Sensitive |
| ENSG00000231709.1 |
Gefitinib |
Breast invasive carcinoma |
0.001973489 |
Sensitive |
| ENSG00000231920.1 |
Gefitinib |
Breast invasive carcinoma |
0.006245807 |
Sensitive |
| ENSG00000232093.1 |
Gefitinib |
Breast invasive carcinoma |
0.010647522 |
Sensitive |
| ENSG00000233006.2 |
Gefitinib |
Breast invasive carcinoma |
0.030167415 |
Sensitive |
| ENSG00000233013.4 |
Gefitinib |
Breast invasive carcinoma |
0.043116758 |
Sensitive |
| ENSG00000233483.2 |
Gefitinib |
Breast invasive carcinoma |
0.026041092 |
Sensitive |
| ENSG00000233694.1 |
Gefitinib |
Breast invasive carcinoma |
0.022589974 |
Sensitive |
| ENSG00000233834.2 |
Gefitinib |
Breast invasive carcinoma |
0.033018788 |
Sensitive |
| ENSG00000233901.1 |
Gefitinib |
Breast invasive carcinoma |
0.030130974 |
Sensitive |
| ENSG00000233930.3 |
Gefitinib |
Breast invasive carcinoma |
0.017980247 |
Sensitive |
| ENSG00000234111.2 |
Gefitinib |
Breast invasive carcinoma |
0.017056202 |
Sensitive |
| ENSG00000234546.2 |
Gefitinib |
Breast invasive carcinoma |
0.032985212 |
Sensitive |
| ENSG00000234678.1 |
Gefitinib |
Breast invasive carcinoma |
0.041682752 |
Sensitive |
| ENSG00000235526.1 |
Gefitinib |
Breast invasive carcinoma |
0.040453512 |
Sensitive |
| ENSG00000235609.4 |
Gefitinib |
Breast invasive carcinoma |
0.023211258 |
Sensitive |
| ENSG00000235772.1 |
Gefitinib |
Breast invasive carcinoma |
0.043597102 |
Sensitive |
| ENSG00000236204.1 |
Gefitinib |
Breast invasive carcinoma |
0.047958765 |
Sensitive |
| ENSG00000236438.2 |
Gefitinib |
Breast invasive carcinoma |
0.016308817 |
Sensitive |
| ENSG00000236601.1 |
Gefitinib |
Breast invasive carcinoma |
0.020388267 |
Sensitive |
| ENSG00000236743.1 |
Gefitinib |
Breast invasive carcinoma |
0.031558953 |
Sensitive |
| ENSG00000236830.2 |
Gefitinib |
Breast invasive carcinoma |
0.045732067 |
Sensitive |
| ENSG00000237094.7 |
Gefitinib |
Breast invasive carcinoma |
0.011603416 |
Sensitive |
| ENSG00000237520.1 |
Gefitinib |
Breast invasive carcinoma |
0.023011688 |
Sensitive |
| ENSG00000237883.1 |
Gefitinib |
Breast invasive carcinoma |
0.018647997 |
Sensitive |
| ENSG00000238005.2 |
Gefitinib |
Breast invasive carcinoma |
0.009596078 |
Sensitive |
| ENSG00000238035.4 |
Gefitinib |
Breast invasive carcinoma |
0.016047853 |
Sensitive |
| ENSG00000239906.1 |
Gefitinib |
Breast invasive carcinoma |
0.046391927 |
Sensitive |
| ENSG00000240618.1 |
Gefitinib |
Breast invasive carcinoma |
0.040832408 |
Sensitive |
| ENSG00000241599.1 |
Gefitinib |
Breast invasive carcinoma |
0.034822567 |
Sensitive |
| ENSG00000241860.2 |
Gefitinib |
Breast invasive carcinoma |
0.037347415 |
Sensitive |
| ENSG00000242136.1 |
Gefitinib |
Breast invasive carcinoma |
0.033436031 |
Sensitive |
| ENSG00000243885.1 |
Gefitinib |
Breast invasive carcinoma |
0.034213372 |
Sensitive |
| ENSG00000244541.1 |
Gefitinib |
Breast invasive carcinoma |
0.024984969 |
Sensitive |
| ENSG00000246526.2 |
Gefitinib |
Breast invasive carcinoma |
0.014144299 |
Sensitive |
| ENSG00000246740.2 |
Gefitinib |
Breast invasive carcinoma |
0.02256007 |
Sensitive |
| ENSG00000246790.2 |
Gefitinib |
Breast invasive carcinoma |
0.041000984 |
Sensitive |
| ENSG00000247287.2 |
Gefitinib |
Breast invasive carcinoma |
0.002736746 |
Sensitive |
| ENSG00000248494.1 |
Gefitinib |
Breast invasive carcinoma |
0.014429928 |
Sensitive |
| ENSG00000248968.1 |
Gefitinib |
Breast invasive carcinoma |
0.007353892 |
Sensitive |
| ENSG00000249042.1 |
Gefitinib |
Breast invasive carcinoma |
0.036693692 |
Sensitive |
| ENSG00000249173.1 |
Gefitinib |
Breast invasive carcinoma |
0.038281861 |
Sensitive |
| ENSG00000249641.2 |
Gefitinib |
Breast invasive carcinoma |
0.017262122 |
Sensitive |
| ENSG00000249700.4 |
Gefitinib |
Breast invasive carcinoma |
0.011836612 |
Sensitive |
| ENSG00000250295.2 |
Gefitinib |
Breast invasive carcinoma |
0.046077297 |
Sensitive |
| ENSG00000250522.1 |
Gefitinib |
Breast invasive carcinoma |
0.042541681 |
Sensitive |
| ENSG00000250994.1 |
Gefitinib |
Breast invasive carcinoma |
0.040270392 |
Sensitive |
| ENSG00000250999.1 |
Gefitinib |
Breast invasive carcinoma |
0.02018841 |
Sensitive |
| ENSG00000251298.1 |
Gefitinib |
Breast invasive carcinoma |
0.044358283 |
Sensitive |
| ENSG00000251675.1 |
Gefitinib |
Breast invasive carcinoma |
0.018154676 |
Sensitive |
| ENSG00000251687.1 |
Gefitinib |
Breast invasive carcinoma |
0.00876165 |
Sensitive |
| ENSG00000253477.1 |
Gefitinib |
Breast invasive carcinoma |
0.047603094 |
Sensitive |
| ENSG00000253671.1 |
Gefitinib |
Breast invasive carcinoma |
0.019221972 |
Sensitive |
| ENSG00000253972.1 |
Gefitinib |
Breast invasive carcinoma |
0.047083413 |
Sensitive |
| ENSG00000254039.1 |
Gefitinib |
Breast invasive carcinoma |
0.024584333 |
Sensitive |
| ENSG00000254109.1 |
Gefitinib |
Breast invasive carcinoma |
0.011054047 |
Sensitive |
| ENSG00000254267.1 |
Gefitinib |
Breast invasive carcinoma |
0.025637273 |
Sensitive |
| ENSG00000254286.1 |
Gefitinib |
Breast invasive carcinoma |
0.037592916 |
Sensitive |
| ENSG00000254551.1 |
Gefitinib |
Breast invasive carcinoma |
0.046781193 |
Sensitive |
| ENSG00000254676.1 |
Gefitinib |
Breast invasive carcinoma |
0.026883388 |
Sensitive |
| ENSG00000255045.1 |
Gefitinib |
Breast invasive carcinoma |
0.008191028 |
Sensitive |
| ENSG00000255145.1 |
Gefitinib |
Breast invasive carcinoma |
0.031679135 |
Sensitive |
| ENSG00000255229.1 |
Gefitinib |
Breast invasive carcinoma |
0.030312338 |
Sensitive |
| ENSG00000255247.1 |
Gefitinib |
Breast invasive carcinoma |
0.006950945 |
Sensitive |
| ENSG00000257084.1 |
Gefitinib |
Breast invasive carcinoma |
0.009577087 |
Sensitive |
| ENSG00000257671.1 |
Gefitinib |
Breast invasive carcinoma |
0.036822043 |
Sensitive |
| ENSG00000258442.1 |
Gefitinib |
Breast invasive carcinoma |
0.032948887 |
Sensitive |
| ENSG00000258882.1 |
Gefitinib |
Breast invasive carcinoma |
0.017266504 |
Sensitive |
| ENSG00000258903.1 |
Gefitinib |
Breast invasive carcinoma |
0.03134442 |
Sensitive |
| ENSG00000259083.1 |
Gefitinib |
Breast invasive carcinoma |
0.045975778 |
Sensitive |
| ENSG00000259087.1 |
Gefitinib |
Breast invasive carcinoma |
0.001894492 |
Sensitive |
| ENSG00000259153.1 |
Gefitinib |
Breast invasive carcinoma |
0.018439358 |
Sensitive |
| ENSG00000259617.1 |
Gefitinib |
Breast invasive carcinoma |
0.03297952 |
Sensitive |
| ENSG00000259644.1 |
Gefitinib |
Breast invasive carcinoma |
0.000606419 |
Sensitive |
| ENSG00000259796.1 |
Gefitinib |
Breast invasive carcinoma |
0.012208853 |
Sensitive |
| ENSG00000259840.1 |
Gefitinib |
Breast invasive carcinoma |
0.04285683 |
Sensitive |
| ENSG00000259925.1 |
Gefitinib |
Breast invasive carcinoma |
0.017725603 |
Sensitive |
| ENSG00000260430.1 |
Gefitinib |
Breast invasive carcinoma |
0.031276752 |
Sensitive |
| ENSG00000260528.2 |
Gefitinib |
Breast invasive carcinoma |
0.048443278 |
Sensitive |
| ENSG00000260572.1 |
Gefitinib |
Breast invasive carcinoma |
0.042183373 |
Sensitive |
| ENSG00000260648.2 |
Gefitinib |
Breast invasive carcinoma |
0.048480903 |
Sensitive |
| ENSG00000260742.1 |
Gefitinib |
Breast invasive carcinoma |
0.026693882 |
Sensitive |
| ENSG00000260923.1 |
Gefitinib |
Breast invasive carcinoma |
0.037983243 |
Sensitive |
| ENSG00000260989.1 |
Gefitinib |
Breast invasive carcinoma |
0.009429256 |
Sensitive |
| ENSG00000260992.1 |
Gefitinib |
Breast invasive carcinoma |
0.036264228 |
Sensitive |
| ENSG00000261068.1 |
Gefitinib |
Breast invasive carcinoma |
0.026623997 |
Sensitive |
| ENSG00000261104.1 |
Gefitinib |
Breast invasive carcinoma |
0.042502675 |
Sensitive |
| ENSG00000261114.1 |
Gefitinib |
Breast invasive carcinoma |
0.037651777 |
Sensitive |
| ENSG00000261172.1 |
Gefitinib |
Breast invasive carcinoma |
0.029598535 |
Sensitive |
| ENSG00000261183.1 |
Gefitinib |
Breast invasive carcinoma |
0.00121945 |
Sensitive |
| ENSG00000261211.1 |
Gefitinib |
Breast invasive carcinoma |
0.038867799 |
Sensitive |
| ENSG00000261267.1 |
Gefitinib |
Breast invasive carcinoma |
0.022381401 |
Sensitive |
| ENSG00000261270.1 |
Gefitinib |
Breast invasive carcinoma |
0.049666495 |
Sensitive |
| ENSG00000261437.1 |
Gefitinib |
Breast invasive carcinoma |
0.028150949 |
Sensitive |
| ENSG00000261572.1 |
Gefitinib |
Breast invasive carcinoma |
0.033010478 |
Sensitive |
| ENSG00000261654.1 |
Gefitinib |
Breast invasive carcinoma |
0.021740392 |
Sensitive |
| ENSG00000261760.2 |
Gefitinib |
Breast invasive carcinoma |
0.044387695 |
Sensitive |
| ENSG00000262094.1 |
Gefitinib |
Breast invasive carcinoma |
0.006069618 |
Sensitive |
| ENSG00000262362.1 |
Gefitinib |
Breast invasive carcinoma |
0.010552747 |
Sensitive |
| ENSG00000262823.1 |
Gefitinib |
Breast invasive carcinoma |
0.045888358 |
Sensitive |
| ENSG00000262952.1 |
Gefitinib |
Breast invasive carcinoma |
0.002801173 |
Sensitive |
| ENSG00000266445.1 |
Gefitinib |
Breast invasive carcinoma |
0.046557365 |
Sensitive |
| ENSG00000266578.1 |
Gefitinib |
Breast invasive carcinoma |
0.046741849 |
Sensitive |
| ENSG00000266900.1 |
Gefitinib |
Breast invasive carcinoma |
0.00527168 |
Sensitive |
| ENSG00000266921.1 |
Gefitinib |
Breast invasive carcinoma |
0.04794872 |
Sensitive |
| ENSG00000267174.1 |
Gefitinib |
Breast invasive carcinoma |
0.022126622 |
Sensitive |
| ENSG00000267308.1 |
Gefitinib |
Breast invasive carcinoma |
0.038451472 |
Sensitive |
| ENSG00000268061.1 |
Gefitinib |
Breast invasive carcinoma |
0.016360297 |
Sensitive |
| ENSG00000268707.1 |
Gefitinib |
Breast invasive carcinoma |
0.033716088 |
Sensitive |
| ENSG00000270124.1 |
Gefitinib |
Breast invasive carcinoma |
0.02641776 |
Sensitive |
| ENSG00000270177.1 |
Gefitinib |
Breast invasive carcinoma |
0.032024217 |
Sensitive |
| ENSG00000270571.2 |
Gefitinib |
Breast invasive carcinoma |
0.006931851 |
Sensitive |
| ENSG00000271218.1 |
Gefitinib |
Breast invasive carcinoma |
0.03047444 |
Sensitive |
| ENSG00000271366.1 |
Gefitinib |
Breast invasive carcinoma |
0.025196968 |
Sensitive |
| ENSG00000271830.1 |
Gefitinib |
Breast invasive carcinoma |
0.040043199 |
Sensitive |
| ENSG00000271917.1 |
Gefitinib |
Breast invasive carcinoma |
0.011352212 |
Sensitive |
| ENSG00000271921.1 |
Gefitinib |
Breast invasive carcinoma |
0.036569377 |
Sensitive |
| ENSG00000271983.1 |
Gefitinib |
Breast invasive carcinoma |
0.018694856 |
Sensitive |
| ENSG00000272030.1 |
Gefitinib |
Breast invasive carcinoma |
0.030776793 |
Sensitive |
| ENSG00000272079.1 |
Gefitinib |
Breast invasive carcinoma |
0.008187728 |
Sensitive |
| ENSG00000272384.1 |
Gefitinib |
Breast invasive carcinoma |
0.036495365 |
Sensitive |
| ENSG00000272672.1 |
Gefitinib |
Breast invasive carcinoma |
0.038126755 |
Sensitive |
| ENSG00000272717.1 |
Gefitinib |
Breast invasive carcinoma |
0.00255435 |
Sensitive |
| ENSG00000272721.1 |
Gefitinib |
Breast invasive carcinoma |
0.019033091 |
Sensitive |
| ENSG00000272732.1 |
Gefitinib |
Breast invasive carcinoma |
0.001847873 |
Sensitive |
| ENSG00000272832.1 |
Gefitinib |
Breast invasive carcinoma |
0.018845254 |
Sensitive |
| ENSG00000272894.1 |
Gefitinib |
Breast invasive carcinoma |
0.000115269 |
Sensitive |
| ENSG00000272954.1 |
Gefitinib |
Breast invasive carcinoma |
0.025757545 |
Sensitive |
| ENSG00000273328.1 |
Gefitinib |
Breast invasive carcinoma |
0.025905319 |
Sensitive |
| ENSG00000273373.1 |
Gefitinib |
Breast invasive carcinoma |
0.039483374 |
Sensitive |
| ENSG00000273375.1 |
Gefitinib |
Breast invasive carcinoma |
0.04350274 |
Sensitive |
| ENSG00000273381.1 |
Gefitinib |
Breast invasive carcinoma |
0.036922822 |
Sensitive |
| ENSG00000273399.1 |
Gefitinib |
Breast invasive carcinoma |
0.040141477 |
Sensitive |
| ENSG00000226125.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039335247 |
Sensitive |
| ENSG00000226386.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02713346 |
Sensitive |
| ENSG00000227512.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.013295978 |
Sensitive |
| ENSG00000231134.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01858583 |
Sensitive |
| ENSG00000233429.5 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03442247 |
Sensitive |
| ENSG00000233554.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022602965 |
Sensitive |
| ENSG00000233845.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042433677 |
Sensitive |
| ENSG00000235529.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.004679114 |
Sensitive |
| ENSG00000236393.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015428369 |
Sensitive |
| ENSG00000238120.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019462569 |
Sensitive |
| ENSG00000238260.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016917399 |
Sensitive |
| ENSG00000241211.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009886196 |
Sensitive |
| ENSG00000246130.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036461706 |
Sensitive |
| ENSG00000248079.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.018139955 |
Sensitive |
| ENSG00000248734.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043674301 |
Sensitive |
| ENSG00000251003.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002537914 |
Sensitive |
| ENSG00000251359.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015152363 |
Sensitive |
| ENSG00000251432.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005796245 |
Sensitive |
| ENSG00000253552.3 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035115188 |
Sensitive |
| ENSG00000254109.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022230631 |
Sensitive |
| ENSG00000255989.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045022253 |
Sensitive |
| ENSG00000256940.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019514147 |
Sensitive |
| ENSG00000257252.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032452237 |
Sensitive |
| ENSG00000257279.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023279052 |
Sensitive |
| ENSG00000257474.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014539673 |
Sensitive |
| ENSG00000257671.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005792709 |
Sensitive |
| ENSG00000258414.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031525713 |
Sensitive |
| ENSG00000260179.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027520979 |
Sensitive |
| ENSG00000261780.2 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.002817354 |
Sensitive |
| ENSG00000266371.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038568696 |
Sensitive |
| ENSG00000266942.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033789579 |
Sensitive |
| ENSG00000267069.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02264737 |
Sensitive |
| ENSG00000269082.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037459872 |
Sensitive |
| ENSG00000270640.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009105054 |
Sensitive |
| ENSG00000271966.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.029527738 |
Sensitive |
| ENSG00000170590.4 |
Gefitinib |
Esophageal cancer |
0.043334738 |
Sensitive |
| ENSG00000171889.3 |
Gefitinib |
Esophageal cancer |
0.024975878 |
Sensitive |
| ENSG00000186615.6 |
Gefitinib |
Esophageal cancer |
0.010948986 |
Sensitive |
| ENSG00000206195.6 |
Gefitinib |
Esophageal cancer |
0.018344359 |
Sensitive |
| ENSG00000213971.3 |
Gefitinib |
Esophageal cancer |
0.02620428 |
Sensitive |
| ENSG00000214432.5 |
Gefitinib |
Esophageal cancer |
0.02344387 |
Sensitive |
| ENSG00000214770.2 |
Gefitinib |
Esophageal cancer |
0.032024698 |
Sensitive |
| ENSG00000219665.4 |
Gefitinib |
Esophageal cancer |
0.012468483 |
Sensitive |
| ENSG00000223960.2 |
Gefitinib |
Esophageal cancer |
0.036730485 |
Sensitive |
| ENSG00000224189.2 |
Gefitinib |
Esophageal cancer |
0.002712677 |
Sensitive |
| ENSG00000224897.2 |
Gefitinib |
Esophageal cancer |
0.031636662 |
Sensitive |
| ENSG00000225163.3 |
Gefitinib |
Esophageal cancer |
0.040155774 |
Sensitive |
| ENSG00000225177.1 |
Gefitinib |
Esophageal cancer |
0.025389577 |
Sensitive |
| ENSG00000225210.5 |
Gefitinib |
Esophageal cancer |
0.020635642 |
Sensitive |
| ENSG00000226386.1 |
Gefitinib |
Esophageal cancer |
0.044175305 |
Sensitive |
| ENSG00000226562.2 |
Gefitinib |
Esophageal cancer |
0.029973049 |
Sensitive |
| ENSG00000226852.2 |
Gefitinib |
Esophageal cancer |
0.037108593 |
Sensitive |
| ENSG00000226883.1 |
Gefitinib |
Esophageal cancer |
0.03649893 |
Sensitive |
| ENSG00000227214.2 |
Gefitinib |
Esophageal cancer |
0.005044018 |
Sensitive |
| ENSG00000227617.4 |
Gefitinib |
Esophageal cancer |
0.007109086 |
Sensitive |
| ENSG00000227640.2 |
Gefitinib |
Esophageal cancer |
0.047256494 |
Sensitive |
| ENSG00000227674.1 |
Gefitinib |
Esophageal cancer |
0.039520814 |
Sensitive |
| ENSG00000227953.2 |
Gefitinib |
Esophageal cancer |
0.005549975 |
Sensitive |
| ENSG00000228221.1 |
Gefitinib |
Esophageal cancer |
0.04005833 |
Sensitive |
| ENSG00000228274.3 |
Gefitinib |
Esophageal cancer |
0.018106283 |
Sensitive |
| ENSG00000228614.1 |
Gefitinib |
Esophageal cancer |
0.000342072 |
Sensitive |
| ENSG00000228649.4 |
Gefitinib |
Esophageal cancer |
0.027686123 |
Sensitive |
| ENSG00000229278.1 |
Gefitinib |
Esophageal cancer |
0.007005121 |
Sensitive |
| ENSG00000229852.2 |
Gefitinib |
Esophageal cancer |
0.02969718 |
Sensitive |
| ENSG00000229905.1 |
Gefitinib |
Esophageal cancer |
0.037365834 |
Sensitive |
| ENSG00000229952.1 |
Gefitinib |
Esophageal cancer |
0.017230735 |
Sensitive |
| ENSG00000230068.2 |
Gefitinib |
Esophageal cancer |
0.014812371 |
Sensitive |
| ENSG00000230513.1 |
Gefitinib |
Esophageal cancer |
0.011037519 |
Sensitive |
| ENSG00000230925.3 |
Gefitinib |
Esophageal cancer |
0.0414678 |
Sensitive |
| ENSG00000231764.4 |
Gefitinib |
Esophageal cancer |
0.042287978 |
Sensitive |
| ENSG00000231865.1 |
Gefitinib |
Esophageal cancer |
0.018501276 |
Sensitive |
| ENSG00000231999.2 |
Gefitinib |
Esophageal cancer |
0.022186945 |
Sensitive |
| ENSG00000232164.1 |
Gefitinib |
Esophageal cancer |
0.036835246 |
Sensitive |
| ENSG00000232316.1 |
Gefitinib |
Esophageal cancer |
0.018986558 |
Sensitive |
| ENSG00000232586.1 |
Gefitinib |
Esophageal cancer |
0.024677452 |
Sensitive |
| ENSG00000232677.2 |
Gefitinib |
Esophageal cancer |
0.039648829 |
Sensitive |
| ENSG00000234650.1 |
Gefitinib |
Esophageal cancer |
0.020304151 |
Sensitive |
| ENSG00000236438.2 |
Gefitinib |
Esophageal cancer |
0.023247987 |
Sensitive |
| ENSG00000236618.2 |
Gefitinib |
Esophageal cancer |
0.047708657 |
Sensitive |
| ENSG00000236711.2 |
Gefitinib |
Esophageal cancer |
0.04154981 |
Sensitive |
| ENSG00000237328.1 |
Gefitinib |
Esophageal cancer |
0.02532824 |
Sensitive |
| ENSG00000238113.2 |
Gefitinib |
Esophageal cancer |
0.030836877 |
Sensitive |
| ENSG00000238198.1 |
Gefitinib |
Esophageal cancer |
0.006083159 |
Sensitive |
| ENSG00000239608.1 |
Gefitinib |
Esophageal cancer |
0.013352908 |
Sensitive |
| ENSG00000240922.1 |
Gefitinib |
Esophageal cancer |
0.043603388 |
Sensitive |
| ENSG00000242125.2 |
Gefitinib |
Esophageal cancer |
0.016641578 |
Sensitive |
| ENSG00000242474.1 |
Gefitinib |
Esophageal cancer |
0.045237644 |
Sensitive |
| ENSG00000243701.1 |
Gefitinib |
Esophageal cancer |
0.002529527 |
Sensitive |
| ENSG00000244265.1 |
Gefitinib |
Esophageal cancer |
0.022879308 |
Sensitive |
| ENSG00000244306.5 |
Gefitinib |
Esophageal cancer |
0.020701336 |
Sensitive |
| ENSG00000244327.1 |
Gefitinib |
Esophageal cancer |
0.021016675 |
Sensitive |
| ENSG00000245648.1 |
Gefitinib |
Esophageal cancer |
0.043875692 |
Sensitive |
| ENSG00000245711.2 |
Gefitinib |
Esophageal cancer |
0.033692061 |
Sensitive |
| ENSG00000246090.2 |
Gefitinib |
Esophageal cancer |
0.023879291 |
Sensitive |
| ENSG00000246859.2 |
Gefitinib |
Esophageal cancer |
0.040147773 |
Sensitive |
| ENSG00000246863.2 |
Gefitinib |
Esophageal cancer |
0.041096243 |
Sensitive |
| ENSG00000247134.2 |
Gefitinib |
Esophageal cancer |
0.022046802 |
Sensitive |
| ENSG00000247287.2 |
Gefitinib |
Esophageal cancer |
0.047583966 |
Sensitive |
| ENSG00000247708.3 |
Gefitinib |
Esophageal cancer |
0.025140939 |
Sensitive |
| ENSG00000248240.1 |
Gefitinib |
Esophageal cancer |
0.020742024 |
Sensitive |
| ENSG00000248268.1 |
Gefitinib |
Esophageal cancer |
0.010710859 |
Sensitive |
| ENSG00000248554.1 |
Gefitinib |
Esophageal cancer |
0.022252821 |
Sensitive |
| ENSG00000248596.2 |
Gefitinib |
Esophageal cancer |
0.017034066 |
Sensitive |
| ENSG00000248773.1 |
Gefitinib |
Esophageal cancer |
0.02474816 |
Sensitive |
| ENSG00000249430.1 |
Gefitinib |
Esophageal cancer |
0.035893412 |
Sensitive |
| ENSG00000249593.2 |
Gefitinib |
Esophageal cancer |
0.023754766 |
Sensitive |
| ENSG00000249790.2 |
Gefitinib |
Esophageal cancer |
0.008126447 |
Sensitive |
| ENSG00000250132.2 |
Gefitinib |
Esophageal cancer |
0.029938193 |
Sensitive |
| ENSG00000250999.1 |
Gefitinib |
Esophageal cancer |
0.020208265 |
Sensitive |
| ENSG00000251330.3 |
Gefitinib |
Esophageal cancer |
0.011044277 |
Sensitive |
| ENSG00000251381.2 |
Gefitinib |
Esophageal cancer |
0.019921217 |
Sensitive |
| ENSG00000251556.1 |
Gefitinib |
Esophageal cancer |
0.033143325 |
Sensitive |
| ENSG00000253706.1 |
Gefitinib |
Esophageal cancer |
0.00000516 |
Sensitive |
| ENSG00000253878.1 |
Gefitinib |
Esophageal cancer |
0.023674522 |
Sensitive |
| ENSG00000254414.1 |
Gefitinib |
Esophageal cancer |
0.025839477 |
Sensitive |
| ENSG00000254468.1 |
Gefitinib |
Esophageal cancer |
0.021222951 |
Sensitive |
| ENSG00000254604.1 |
Gefitinib |
Esophageal cancer |
0.043232602 |
Sensitive |
| ENSG00000255247.1 |
Gefitinib |
Esophageal cancer |
0.009273289 |
Sensitive |
| ENSG00000255421.1 |
Gefitinib |
Esophageal cancer |
0.022035363 |
Sensitive |
| ENSG00000256146.1 |
Gefitinib |
Esophageal cancer |
0.038525967 |
Sensitive |
| ENSG00000257475.2 |
Gefitinib |
Esophageal cancer |
0.029058061 |
Sensitive |
| ENSG00000257894.1 |
Gefitinib |
Esophageal cancer |
0.04419815 |
Sensitive |
| ENSG00000257964.1 |
Gefitinib |
Esophageal cancer |
0.03767869 |
Sensitive |
| ENSG00000258355.1 |
Gefitinib |
Esophageal cancer |
0.038313717 |
Sensitive |
| ENSG00000258441.1 |
Gefitinib |
Esophageal cancer |
0.024496153 |
Sensitive |
| ENSG00000258479.1 |
Gefitinib |
Esophageal cancer |
0.04536426 |
Sensitive |
| ENSG00000258851.1 |
Gefitinib |
Esophageal cancer |
0.002555507 |
Sensitive |
| ENSG00000258959.1 |
Gefitinib |
Esophageal cancer |
0.044435589 |
Sensitive |
| ENSG00000259031.1 |
Gefitinib |
Esophageal cancer |
0.021267826 |
Sensitive |
| ENSG00000259081.1 |
Gefitinib |
Esophageal cancer |
0.031644141 |
Sensitive |
| ENSG00000259135.1 |
Gefitinib |
Esophageal cancer |
0.03640592 |
Sensitive |
| ENSG00000259287.1 |
Gefitinib |
Esophageal cancer |
0.015440816 |
Sensitive |
| ENSG00000259408.1 |
Gefitinib |
Esophageal cancer |
0.043114244 |
Sensitive |
| ENSG00000259424.1 |
Gefitinib |
Esophageal cancer |
0.030930286 |
Sensitive |
| ENSG00000259445.1 |
Gefitinib |
Esophageal cancer |
0.027055288 |
Sensitive |
| ENSG00000259488.1 |
Gefitinib |
Esophageal cancer |
0.003947007 |
Sensitive |
| ENSG00000259692.1 |
Gefitinib |
Esophageal cancer |
0.007847399 |
Sensitive |
| ENSG00000259768.3 |
Gefitinib |
Esophageal cancer |
0.012634156 |
Sensitive |
| ENSG00000259782.2 |
Gefitinib |
Esophageal cancer |
0.016728843 |
Sensitive |
| ENSG00000259783.1 |
Gefitinib |
Esophageal cancer |
0.026919555 |
Sensitive |
| ENSG00000259894.1 |
Gefitinib |
Esophageal cancer |
0.035171905 |
Sensitive |
| ENSG00000259901.1 |
Gefitinib |
Esophageal cancer |
0.044843434 |
Sensitive |
| ENSG00000260265.1 |
Gefitinib |
Esophageal cancer |
0.006510569 |
Sensitive |
| ENSG00000260351.1 |
Gefitinib |
Esophageal cancer |
0.042332744 |
Sensitive |
| ENSG00000260475.1 |
Gefitinib |
Esophageal cancer |
0.030357561 |
Sensitive |
| ENSG00000260579.1 |
Gefitinib |
Esophageal cancer |
0.00029514 |
Sensitive |
| ENSG00000260743.1 |
Gefitinib |
Esophageal cancer |
0.025153884 |
Sensitive |
| ENSG00000260744.1 |
Gefitinib |
Esophageal cancer |
0.043277957 |
Sensitive |
| ENSG00000260830.1 |
Gefitinib |
Esophageal cancer |
0.036874555 |
Sensitive |
| ENSG00000260855.1 |
Gefitinib |
Esophageal cancer |
0.024371347 |
Sensitive |
| ENSG00000261187.1 |
Gefitinib |
Esophageal cancer |
0.049765966 |
Sensitive |
| ENSG00000261879.1 |
Gefitinib |
Esophageal cancer |
0.003103098 |
Sensitive |
| ENSG00000261996.1 |
Gefitinib |
Esophageal cancer |
0.024747257 |
Sensitive |
| ENSG00000262228.1 |
Gefitinib |
Esophageal cancer |
0.035601046 |
Sensitive |
| ENSG00000262434.1 |
Gefitinib |
Esophageal cancer |
0.028099222 |
Sensitive |
| ENSG00000263931.1 |
Gefitinib |
Esophageal cancer |
0.030078678 |
Sensitive |
| ENSG00000264107.1 |
Gefitinib |
Esophageal cancer |
0.030248991 |
Sensitive |
| ENSG00000266538.1 |
Gefitinib |
Esophageal cancer |
0.025042454 |
Sensitive |
| ENSG00000266709.1 |
Gefitinib |
Esophageal cancer |
0.043528137 |
Sensitive |
| ENSG00000267161.1 |
Gefitinib |
Esophageal cancer |
0.033372038 |
Sensitive |
| ENSG00000267280.1 |
Gefitinib |
Esophageal cancer |
0.0363113 |
Sensitive |
| ENSG00000267298.1 |
Gefitinib |
Esophageal cancer |
0.024129282 |
Sensitive |
| ENSG00000267510.1 |
Gefitinib |
Esophageal cancer |
0.003764329 |
Sensitive |
| ENSG00000267758.1 |
Gefitinib |
Esophageal cancer |
0.039881608 |
Sensitive |
| ENSG00000268049.1 |
Gefitinib |
Esophageal cancer |
0.045463539 |
Sensitive |
| ENSG00000268230.1 |
Gefitinib |
Esophageal cancer |
0.02464526 |
Sensitive |
| ENSG00000268543.1 |
Gefitinib |
Esophageal cancer |
0.008266931 |
Sensitive |
| ENSG00000269107.1 |
Gefitinib |
Esophageal cancer |
0.027852413 |
Sensitive |
| ENSG00000270115.1 |
Gefitinib |
Esophageal cancer |
0.0175716 |
Sensitive |
| ENSG00000270933.1 |
Gefitinib |
Esophageal cancer |
0.038910621 |
Sensitive |
| ENSG00000271553.1 |
Gefitinib |
Esophageal cancer |
0.047210207 |
Sensitive |
| ENSG00000272009.1 |
Gefitinib |
Esophageal cancer |
0.036876397 |
Sensitive |
| ENSG00000272452.1 |
Gefitinib |
Esophageal cancer |
0.0436401 |
Sensitive |
| ENSG00000272529.1 |
Gefitinib |
Esophageal cancer |
0.03553965 |
Sensitive |
| ENSG00000273008.1 |
Gefitinib |
Esophageal cancer |
0.038475948 |
Sensitive |
| ENSG00000273190.1 |
Gefitinib |
Esophageal cancer |
0.035740432 |
Sensitive |
| ENSG00000273218.1 |
Gefitinib |
Esophageal cancer |
0.042622559 |
Sensitive |
| ENSG00000225140.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.013517634 |
Sensitive |
| ENSG00000225982.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.010590534 |
Sensitive |
| ENSG00000227403.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.048633208 |
Sensitive |
| ENSG00000227954.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.005094532 |
Sensitive |
| ENSG00000228135.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.002322761 |
Sensitive |
| ENSG00000231530.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.031772912 |
Sensitive |
| ENSG00000233237.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.023571771 |
Sensitive |
| ENSG00000234772.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.045702056 |
Sensitive |
| ENSG00000235244.3 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.023397086 |
Sensitive |
| ENSG00000235852.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.042242461 |
Sensitive |
| ENSG00000236333.3 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.045109767 |
Sensitive |
| ENSG00000237073.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.01840579 |
Sensitive |
| ENSG00000245059.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.007898528 |
Sensitive |
| ENSG00000249145.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.047061663 |
Sensitive |
| ENSG00000249669.3 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.003469685 |
Sensitive |
| ENSG00000250509.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.011244604 |
Sensitive |
| ENSG00000258537.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.040069071 |
Sensitive |
| ENSG00000259744.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.010834623 |
Sensitive |
| ENSG00000260787.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.022253482 |
Sensitive |
| ENSG00000261183.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.049416875 |
Sensitive |
| ENSG00000261455.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.025958277 |
Sensitive |
| ENSG00000264968.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.036251958 |
Sensitive |
| ENSG00000266667.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.042381922 |
Sensitive |
| ENSG00000268189.2 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.03806698 |
Sensitive |
| ENSG00000272141.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.032653456 |
Sensitive |
| ENSG00000273125.1 |
Gefitinib |
Head and neck squamous cell carcinoma |
0.013798752 |
Sensitive |
| ENSG00000226363.3 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.015861201 |
Sensitive |
| ENSG00000226562.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.035853042 |
Sensitive |
| ENSG00000227895.4 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.004829895 |
Sensitive |
| ENSG00000230107.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.03415071 |
Sensitive |
| ENSG00000231948.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.015218313 |
Sensitive |
| ENSG00000234456.3 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.026506719 |
Sensitive |
| ENSG00000235119.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.019587427 |
Sensitive |
| ENSG00000237975.2 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.026535842 |
Sensitive |
| ENSG00000243885.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.044851924 |
Sensitive |
| ENSG00000244998.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.017125325 |
Sensitive |
| ENSG00000246898.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.003232839 |
Sensitive |
| ENSG00000249610.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.044252172 |
Sensitive |
| ENSG00000260917.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.008966841 |
Sensitive |
| ENSG00000261801.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.034195779 |
Sensitive |
| ENSG00000268913.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.007767383 |
Sensitive |
| ENSG00000270949.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.035162849 |
Sensitive |
| ENSG00000273399.1 |
Gefitinib |
Kidney renal clear cell carcinoma |
0.043910197 |
Sensitive |
| ENSG00000212978.5 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.001880745 |
Sensitive |
| ENSG00000214559.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.002650817 |
Sensitive |
| ENSG00000224992.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.023602025 |
Sensitive |
| ENSG00000228408.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.049848897 |
Sensitive |
| ENSG00000234705.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.043322581 |
Sensitive |
| ENSG00000235214.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.014855224 |
Sensitive |
| ENSG00000237753.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.036105451 |
Sensitive |
| ENSG00000241772.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.022759037 |
Sensitive |
| ENSG00000249859.3 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.015899891 |
Sensitive |
| ENSG00000256381.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.03337643 |
Sensitive |
| ENSG00000261005.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.028994291 |
Sensitive |
| ENSG00000264920.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.049576476 |
Sensitive |
| ENSG00000265206.2 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.007914358 |
Sensitive |
| ENSG00000270000.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.015081994 |
Sensitive |
| ENSG00000271780.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.000902442 |
Sensitive |
| ENSG00000273218.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.000297778 |
Sensitive |
| ENSG00000204832.5 |
Gefitinib |
Brain lower grade glioma |
0.001269384 |
Sensitive |
| ENSG00000224057.1 |
Gefitinib |
Brain lower grade glioma |
0.002978511 |
Sensitive |
| ENSG00000224899.1 |
Gefitinib |
Brain lower grade glioma |
0.023304768 |
Sensitive |
| ENSG00000229190.1 |
Gefitinib |
Brain lower grade glioma |
0.032197323 |
Sensitive |
| ENSG00000234997.1 |
Gefitinib |
Brain lower grade glioma |
0.022397662 |
Sensitive |
| ENSG00000236703.1 |
Gefitinib |
Brain lower grade glioma |
0.049582218 |
Sensitive |
| ENSG00000237513.1 |
Gefitinib |
Brain lower grade glioma |
0.020310776 |
Sensitive |
| ENSG00000249293.1 |
Gefitinib |
Brain lower grade glioma |
0.007607032 |
Sensitive |
| ENSG00000249593.2 |
Gefitinib |
Brain lower grade glioma |
0.03490729 |
Sensitive |
| ENSG00000251230.1 |
Gefitinib |
Brain lower grade glioma |
0.037372737 |
Sensitive |
| ENSG00000253712.1 |
Gefitinib |
Brain lower grade glioma |
0.037409544 |
Sensitive |
| ENSG00000255299.1 |
Gefitinib |
Brain lower grade glioma |
0.018699027 |
Sensitive |
| ENSG00000257256.1 |
Gefitinib |
Brain lower grade glioma |
0.008416077 |
Sensitive |
| ENSG00000257438.1 |
Gefitinib |
Brain lower grade glioma |
0.035418204 |
Sensitive |
| ENSG00000260616.2 |
Gefitinib |
Brain lower grade glioma |
0.040560996 |
Sensitive |
| ENSG00000261804.1 |
Gefitinib |
Brain lower grade glioma |
0.008028574 |
Sensitive |
| ENSG00000262714.1 |
Gefitinib |
Brain lower grade glioma |
0.039608821 |
Sensitive |
| ENSG00000262833.1 |
Gefitinib |
Brain lower grade glioma |
0.048313415 |
Sensitive |
| ENSG00000267375.1 |
Gefitinib |
Brain lower grade glioma |
0.038227484 |
Sensitive |
| ENSG00000267734.1 |
Gefitinib |
Brain lower grade glioma |
0.03761544 |
Sensitive |
| ENSG00000271204.1 |
Gefitinib |
Brain lower grade glioma |
0.018046958 |
Sensitive |
| ENSG00000273009.1 |
Gefitinib |
Brain lower grade glioma |
0.036580752 |
Sensitive |
| ENSG00000175147.7 |
Gefitinib |
Lung squamous cell carcinoma |
0.027045321 |
Sensitive |
| ENSG00000185168.5 |
Gefitinib |
Lung squamous cell carcinoma |
0.043392718 |
Sensitive |
| ENSG00000185186.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.00818792 |
Sensitive |
| ENSG00000189419.5 |
Gefitinib |
Lung squamous cell carcinoma |
0.00713798 |
Sensitive |
| ENSG00000197099.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.020828423 |
Sensitive |
| ENSG00000203499.6 |
Gefitinib |
Lung squamous cell carcinoma |
0.001197458 |
Sensitive |
| ENSG00000204588.5 |
Gefitinib |
Lung squamous cell carcinoma |
0.013426489 |
Sensitive |
| ENSG00000205488.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.042852837 |
Sensitive |
| ENSG00000205890.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.028486854 |
Sensitive |
| ENSG00000214049.6 |
Gefitinib |
Lung squamous cell carcinoma |
0.029672272 |
Sensitive |
| ENSG00000214733.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.035836946 |
Sensitive |
| ENSG00000214894.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.035629743 |
Sensitive |
| ENSG00000215841.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.010219214 |
Sensitive |
| ENSG00000223477.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.02687526 |
Sensitive |
| ENSG00000223734.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.04241878 |
Sensitive |
| ENSG00000223783.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.044914848 |
Sensitive |
| ENSG00000223784.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001417463 |
Sensitive |
| ENSG00000223935.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.03255487 |
Sensitive |
| ENSG00000223975.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035039836 |
Sensitive |
| ENSG00000224349.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.020456965 |
Sensitive |
| ENSG00000224652.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.014449582 |
Sensitive |
| ENSG00000224733.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001056151 |
Sensitive |
| ENSG00000224794.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040146098 |
Sensitive |
| ENSG00000224818.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031715315 |
Sensitive |
| ENSG00000224822.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.008367904 |
Sensitive |
| ENSG00000224984.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007589463 |
Sensitive |
| ENSG00000225205.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04627827 |
Sensitive |
| ENSG00000225778.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.011366618 |
Sensitive |
| ENSG00000225982.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.030689234 |
Sensitive |
| ENSG00000226125.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.026194987 |
Sensitive |
| ENSG00000226276.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.004811229 |
Sensitive |
| ENSG00000226377.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00279374 |
Sensitive |
| ENSG00000227039.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.034450807 |
Sensitive |
| ENSG00000227403.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007622904 |
Sensitive |
| ENSG00000227477.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021946689 |
Sensitive |
| ENSG00000227479.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.020113481 |
Sensitive |
| ENSG00000227486.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018820946 |
Sensitive |
| ENSG00000227702.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.027165138 |
Sensitive |
| ENSG00000227726.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.030737213 |
Sensitive |
| ENSG00000227885.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.038612375 |
Sensitive |
| ENSG00000227959.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.030548489 |
Sensitive |
| ENSG00000228067.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034125635 |
Sensitive |
| ENSG00000228313.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.028580693 |
Sensitive |
| ENSG00000228481.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.02708043 |
Sensitive |
| ENSG00000228526.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.005706161 |
Sensitive |
| ENSG00000228791.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.001380783 |
Sensitive |
| ENSG00000228886.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029794861 |
Sensitive |
| ENSG00000228917.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.033709797 |
Sensitive |
| ENSG00000229021.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.01738775 |
Sensitive |
| ENSG00000229167.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.048272182 |
Sensitive |
| ENSG00000229491.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035440489 |
Sensitive |
| ENSG00000229656.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.032250057 |
Sensitive |
| ENSG00000229672.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.036684453 |
Sensitive |
| ENSG00000229688.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.03274927 |
Sensitive |
| ENSG00000230020.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041479241 |
Sensitive |
| ENSG00000230061.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.011702153 |
Sensitive |
| ENSG00000230133.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018976515 |
Sensitive |
| ENSG00000230408.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.019689941 |
Sensitive |
| ENSG00000230423.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.046764833 |
Sensitive |
| ENSG00000230439.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.047375839 |
Sensitive |
| ENSG00000230698.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024753908 |
Sensitive |
| ENSG00000230753.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019684527 |
Sensitive |
| ENSG00000231483.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024064703 |
Sensitive |
| ENSG00000231709.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.048108287 |
Sensitive |
| ENSG00000232386.5 |
Gefitinib |
Lung squamous cell carcinoma |
0.045628259 |
Sensitive |
| ENSG00000232401.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.025335699 |
Sensitive |
| ENSG00000232973.7 |
Gefitinib |
Lung squamous cell carcinoma |
0.038395809 |
Sensitive |
| ENSG00000233221.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.045697865 |
Sensitive |
| ENSG00000233694.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00356704 |
Sensitive |
| ENSG00000233785.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.030531987 |
Sensitive |
| ENSG00000233845.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022079159 |
Sensitive |
| ENSG00000233901.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045292691 |
Sensitive |
| ENSG00000234111.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.029921542 |
Sensitive |
| ENSG00000234147.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032206012 |
Sensitive |
| ENSG00000234155.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.03033937 |
Sensitive |
| ENSG00000234174.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002363945 |
Sensitive |
| ENSG00000234546.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.012970957 |
Sensitive |
| ENSG00000234678.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.014880157 |
Sensitive |
| ENSG00000234694.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.038474364 |
Sensitive |
| ENSG00000234703.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.046289176 |
Sensitive |
| ENSG00000235295.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041930557 |
Sensitive |
| ENSG00000235522.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.021142017 |
Sensitive |
| ENSG00000235523.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.026042894 |
Sensitive |
| ENSG00000235724.4 |
Gefitinib |
Lung squamous cell carcinoma |
0.007058468 |
Sensitive |
| ENSG00000235781.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.014038219 |
Sensitive |
| ENSG00000236116.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.044919291 |
Sensitive |
| ENSG00000236153.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045782772 |
Sensitive |
| ENSG00000236305.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.000375702 |
Sensitive |
| ENSG00000236384.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.008576402 |
Sensitive |
| ENSG00000236427.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032351648 |
Sensitive |
| ENSG00000236743.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028210992 |
Sensitive |
| ENSG00000237166.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.020271341 |
Sensitive |
| ENSG00000237416.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.041600454 |
Sensitive |
| ENSG00000237453.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002849806 |
Sensitive |
| ENSG00000237773.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028246445 |
Sensitive |
| ENSG00000240005.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045228139 |
Sensitive |
| ENSG00000242147.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031530468 |
Sensitive |
| ENSG00000244541.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.038889342 |
Sensitive |
| ENSG00000245479.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.047395728 |
Sensitive |
| ENSG00000246228.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.001142296 |
Sensitive |
| ENSG00000246375.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.032981501 |
Sensitive |
| ENSG00000246526.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.044587179 |
Sensitive |
| ENSG00000246740.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.005106529 |
Sensitive |
| ENSG00000246898.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.008585882 |
Sensitive |
| ENSG00000247095.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.022725771 |
Sensitive |
| ENSG00000248027.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007033818 |
Sensitive |
| ENSG00000248100.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.019230921 |
Sensitive |
| ENSG00000248429.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021630671 |
Sensitive |
| ENSG00000248758.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.042617239 |
Sensitive |
| ENSG00000248846.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.002591187 |
Sensitive |
| ENSG00000248884.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028160317 |
Sensitive |
| ENSG00000248896.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.024310066 |
Sensitive |
| ENSG00000248964.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.038867875 |
Sensitive |
| ENSG00000249550.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.047442632 |
Sensitive |
| ENSG00000249738.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.013141327 |
Sensitive |
| ENSG00000250072.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.005988724 |
Sensitive |
| ENSG00000250590.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045163651 |
Sensitive |
| ENSG00000250604.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.01778132 |
Sensitive |
| ENSG00000251128.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043233101 |
Sensitive |
| ENSG00000251292.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.016889018 |
Sensitive |
| ENSG00000251603.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001266479 |
Sensitive |
| ENSG00000251611.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.000153452 |
Sensitive |
| ENSG00000253182.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047262292 |
Sensitive |
| ENSG00000253406.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007935857 |
Sensitive |
| ENSG00000253490.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.031904505 |
Sensitive |
| ENSG00000253715.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.037888269 |
Sensitive |
| ENSG00000253824.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022765673 |
Sensitive |
| ENSG00000253911.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00625593 |
Sensitive |
| ENSG00000253972.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.02987127 |
Sensitive |
| ENSG00000254109.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019161183 |
Sensitive |
| ENSG00000254267.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.01691325 |
Sensitive |
| ENSG00000254734.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034302264 |
Sensitive |
| ENSG00000254842.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.042642599 |
Sensitive |
| ENSG00000254951.3 |
Gefitinib |
Lung squamous cell carcinoma |
0.0388225 |
Sensitive |
| ENSG00000254973.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.015207983 |
Sensitive |
| ENSG00000255045.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012656892 |
Sensitive |
| ENSG00000256050.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.021763424 |
Sensitive |
| ENSG00000256433.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.005277912 |
Sensitive |
| ENSG00000257038.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04261507 |
Sensitive |
| ENSG00000257086.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002355235 |
Sensitive |
| ENSG00000257890.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021069373 |
Sensitive |
| ENSG00000258593.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.006967825 |
Sensitive |
| ENSG00000258882.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034173248 |
Sensitive |
| ENSG00000258903.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021717816 |
Sensitive |
| ENSG00000258929.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.007856887 |
Sensitive |
| ENSG00000259038.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043530115 |
Sensitive |
| ENSG00000259062.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04882911 |
Sensitive |
| ENSG00000259342.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029201931 |
Sensitive |
| ENSG00000259354.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.017241412 |
Sensitive |
| ENSG00000259424.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024080055 |
Sensitive |
| ENSG00000259473.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028086132 |
Sensitive |
| ENSG00000259579.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.005766356 |
Sensitive |
| ENSG00000259583.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047447864 |
Sensitive |
| ENSG00000259793.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.011529036 |
Sensitive |
| ENSG00000259796.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.013404651 |
Sensitive |
| ENSG00000260328.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.004961846 |
Sensitive |
| ENSG00000260352.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002213089 |
Sensitive |
| ENSG00000260593.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.007575732 |
Sensitive |
| ENSG00000260633.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.008899907 |
Sensitive |
| ENSG00000260719.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.038312245 |
Sensitive |
| ENSG00000260798.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.014581492 |
Sensitive |
| ENSG00000261000.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.009481339 |
Sensitive |
| ENSG00000261068.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.017928203 |
Sensitive |
| ENSG00000261183.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.000832562 |
Sensitive |
| ENSG00000261220.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.009953375 |
Sensitive |
| ENSG00000261268.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.047833751 |
Sensitive |
| ENSG00000261357.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043701183 |
Sensitive |
| ENSG00000261392.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.038767636 |
Sensitive |
| ENSG00000261469.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021879602 |
Sensitive |
| ENSG00000261690.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034465712 |
Sensitive |
| ENSG00000261692.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.002587838 |
Sensitive |
| ENSG00000262823.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018607093 |
Sensitive |
| ENSG00000262979.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.042095672 |
Sensitive |
| ENSG00000263325.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.02296031 |
Sensitive |
| ENSG00000263709.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.034439614 |
Sensitive |
| ENSG00000264007.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035759108 |
Sensitive |
| ENSG00000264243.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043182421 |
Sensitive |
| ENSG00000264859.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.00147417 |
Sensitive |
| ENSG00000265349.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.019331386 |
Sensitive |
| ENSG00000265666.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035542135 |
Sensitive |
| ENSG00000265888.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043093988 |
Sensitive |
| ENSG00000266088.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021480889 |
Sensitive |
| ENSG00000266278.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.041952439 |
Sensitive |
| ENSG00000266304.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.023796538 |
Sensitive |
| ENSG00000266521.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.021797704 |
Sensitive |
| ENSG00000266869.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.048717425 |
Sensitive |
| ENSG00000267288.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.036343738 |
Sensitive |
| ENSG00000267308.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.028644519 |
Sensitive |
| ENSG00000267311.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.042360537 |
Sensitive |
| ENSG00000267344.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001798155 |
Sensitive |
| ENSG00000267557.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04918439 |
Sensitive |
| ENSG00000268460.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.040235445 |
Sensitive |
| ENSG00000268913.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.029507173 |
Sensitive |
| ENSG00000269680.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.001742902 |
Sensitive |
| ENSG00000269989.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.036714342 |
Sensitive |
| ENSG00000270115.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.020871842 |
Sensitive |
| ENSG00000270190.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.0000391 |
Sensitive |
| ENSG00000270265.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.006596103 |
Sensitive |
| ENSG00000270659.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.035920279 |
Sensitive |
| ENSG00000271366.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022813998 |
Sensitive |
| ENSG00000271983.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.022594105 |
Sensitive |
| ENSG00000272071.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.032198446 |
Sensitive |
| ENSG00000272554.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.003070515 |
Sensitive |
| ENSG00000272666.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.043937657 |
Sensitive |
| ENSG00000272691.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.039903459 |
Sensitive |
| ENSG00000272861.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.045636621 |
Sensitive |
| ENSG00000272862.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.018014554 |
Sensitive |
| ENSG00000273065.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.012816373 |
Sensitive |
| ENSG00000273118.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.017029726 |
Sensitive |
| ENSG00000273295.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.04507361 |
Sensitive |
| ENSG00000273335.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.011068538 |
Sensitive |
| ENSG00000178248.10 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01986478 |
Sensitive |
| ENSG00000186615.6 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047094789 |
Sensitive |
| ENSG00000215190.4 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004919327 |
Sensitive |
| ENSG00000225541.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041977497 |
Sensitive |
| ENSG00000230836.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005342254 |
Sensitive |
| ENSG00000232759.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017866359 |
Sensitive |
| ENSG00000237424.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02396664 |
Sensitive |
| ENSG00000243479.3 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014110873 |
Sensitive |
| ENSG00000244040.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026459799 |
Sensitive |
| ENSG00000248103.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000152876 |
Sensitive |
| ENSG00000254438.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006570264 |
Sensitive |
| ENSG00000255867.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042483489 |
Sensitive |
| ENSG00000257527.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036729269 |
Sensitive |
| ENSG00000258553.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03875466 |
Sensitive |
| ENSG00000258983.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033937271 |
Sensitive |
| ENSG00000260833.2 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010518494 |
Sensitive |
| ENSG00000266149.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016385395 |
Sensitive |
| ENSG00000267758.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042943263 |
Sensitive |
| ENSG00000269082.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047392621 |
Sensitive |
| ENSG00000271631.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033665394 |
Sensitive |
| ENSG00000272627.1 |
Gefitinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03522342 |
Sensitive |
| ENSG00000172965.10 |
Gefitinib |
Pancreatic adenocarcinoma |
0.012995149 |
Sensitive |
| ENSG00000214049.6 |
Gefitinib |
Pancreatic adenocarcinoma |
0.003217771 |
Sensitive |
| ENSG00000214922.5 |
Gefitinib |
Pancreatic adenocarcinoma |
0.028524727 |
Sensitive |
| ENSG00000222041.6 |
Gefitinib |
Pancreatic adenocarcinoma |
0.040314774 |
Sensitive |
| ENSG00000223784.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.001030668 |
Sensitive |
| ENSG00000224468.3 |
Gefitinib |
Pancreatic adenocarcinoma |
0.00669038 |
Sensitive |
| ENSG00000224606.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.014688232 |
Sensitive |
| ENSG00000224738.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.048864545 |
Sensitive |
| ENSG00000224794.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.000123954 |
Sensitive |
| ENSG00000224959.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.003425636 |
Sensitive |
| ENSG00000225439.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.045799902 |
Sensitive |
| ENSG00000226780.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.034807174 |
Sensitive |
| ENSG00000226828.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.017496325 |
Sensitive |
| ENSG00000227431.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.008498852 |
Sensitive |
| ENSG00000228470.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.002315805 |
Sensitive |
| ENSG00000229801.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.022192907 |
Sensitive |
| ENSG00000230176.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.044998481 |
Sensitive |
| ENSG00000230438.5 |
Gefitinib |
Pancreatic adenocarcinoma |
0.03812569 |
Sensitive |
| ENSG00000231187.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.036732104 |
Sensitive |
| ENSG00000231742.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.011654895 |
Sensitive |
| ENSG00000232259.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.032148855 |
Sensitive |
| ENSG00000232527.3 |
Gefitinib |
Pancreatic adenocarcinoma |
0.027917454 |
Sensitive |
| ENSG00000232533.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.009018337 |
Sensitive |
| ENSG00000232623.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.047076232 |
Sensitive |
| ENSG00000233602.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.047675346 |
Sensitive |
| ENSG00000233757.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.042438987 |
Sensitive |
| ENSG00000234913.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.046810053 |
Sensitive |
| ENSG00000235903.3 |
Gefitinib |
Pancreatic adenocarcinoma |
0.000214708 |
Sensitive |
| ENSG00000236933.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.004257458 |
Sensitive |
| ENSG00000237943.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.040841185 |
Sensitive |
| ENSG00000240996.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.008277963 |
Sensitive |
| ENSG00000242759.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.048313913 |
Sensitive |
| ENSG00000243243.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.013501482 |
Sensitive |
| ENSG00000247516.3 |
Gefitinib |
Pancreatic adenocarcinoma |
0.010511981 |
Sensitive |
| ENSG00000248323.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.030442816 |
Sensitive |
| ENSG00000248473.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.001040227 |
Sensitive |
| ENSG00000249310.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.017066576 |
Sensitive |
| ENSG00000250240.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.024553713 |
Sensitive |
| ENSG00000251603.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.046842387 |
Sensitive |
| ENSG00000254699.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.004534944 |
Sensitive |
| ENSG00000255008.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.033152144 |
Sensitive |
| ENSG00000255717.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.020244821 |
Sensitive |
| ENSG00000258323.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.028135892 |
Sensitive |
| ENSG00000258334.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.016529251 |
Sensitive |
| ENSG00000259201.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.02174828 |
Sensitive |
| ENSG00000259396.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.037897881 |
Sensitive |
| ENSG00000260278.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.008142291 |
Sensitive |
| ENSG00000260583.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.026770728 |
Sensitive |
| ENSG00000260585.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.013857936 |
Sensitive |
| ENSG00000260641.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.029681274 |
Sensitive |
| ENSG00000260938.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.044625342 |
Sensitive |
| ENSG00000261195.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.019668857 |
Sensitive |
| ENSG00000261823.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.023347879 |
Sensitive |
| ENSG00000261864.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.003846226 |
Sensitive |
| ENSG00000262265.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.03317925 |
Sensitive |
| ENSG00000263069.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.038019438 |
Sensitive |
| ENSG00000263786.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.001970717 |
Sensitive |
| ENSG00000263847.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.018097435 |
Sensitive |
| ENSG00000265800.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.049647548 |
Sensitive |
| ENSG00000266993.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.029106432 |
Sensitive |
| ENSG00000267308.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.009007003 |
Sensitive |
| ENSG00000267879.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.009901744 |
Sensitive |
| ENSG00000269191.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.043709186 |
Sensitive |
| ENSG00000272248.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.034875905 |
Sensitive |
| ENSG00000272403.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.011724648 |
Sensitive |
| ENSG00000273237.1 |
Gefitinib |
Pancreatic adenocarcinoma |
0.049751251 |
Sensitive |
| ENSG00000177406.4 |
Gefitinib |
Sarcoma |
0.010874549 |
Sensitive |
| ENSG00000185203.7 |
Gefitinib |
Sarcoma |
0.038032655 |
Sensitive |
| ENSG00000214650.2 |
Gefitinib |
Sarcoma |
0.012110582 |
Sensitive |
| ENSG00000215533.4 |
Gefitinib |
Sarcoma |
0.021199899 |
Sensitive |
| ENSG00000223571.1 |
Gefitinib |
Sarcoma |
0.033591604 |
Sensitive |
| ENSG00000223598.1 |
Gefitinib |
Sarcoma |
0.023255101 |
Sensitive |
| ENSG00000223813.2 |
Gefitinib |
Sarcoma |
0.046721012 |
Sensitive |
| ENSG00000223821.1 |
Gefitinib |
Sarcoma |
0.022949253 |
Sensitive |
| ENSG00000225077.2 |
Gefitinib |
Sarcoma |
0.011501597 |
Sensitive |
| ENSG00000225442.2 |
Gefitinib |
Sarcoma |
0.034892194 |
Sensitive |
| ENSG00000227161.1 |
Gefitinib |
Sarcoma |
0.017069251 |
Sensitive |
| ENSG00000228485.1 |
Gefitinib |
Sarcoma |
0.045785308 |
Sensitive |
| ENSG00000228544.1 |
Gefitinib |
Sarcoma |
0.032325193 |
Sensitive |
| ENSG00000228802.1 |
Gefitinib |
Sarcoma |
0.040056652 |
Sensitive |
| ENSG00000231212.1 |
Gefitinib |
Sarcoma |
0.029530266 |
Sensitive |
| ENSG00000231439.3 |
Gefitinib |
Sarcoma |
0.025425058 |
Sensitive |
| ENSG00000231840.1 |
Gefitinib |
Sarcoma |
0.030793045 |
Sensitive |
| ENSG00000232519.2 |
Gefitinib |
Sarcoma |
0.012890911 |
Sensitive |
| ENSG00000234183.1 |
Gefitinib |
Sarcoma |
0.042152831 |
Sensitive |
| ENSG00000235298.1 |
Gefitinib |
Sarcoma |
0.032914286 |
Sensitive |
| ENSG00000235319.1 |
Gefitinib |
Sarcoma |
0.034864744 |
Sensitive |
| ENSG00000236188.1 |
Gefitinib |
Sarcoma |
0.005818336 |
Sensitive |
| ENSG00000236545.1 |
Gefitinib |
Sarcoma |
0.013084709 |
Sensitive |
| ENSG00000243230.1 |
Gefitinib |
Sarcoma |
0.00493574 |
Sensitive |
| ENSG00000244265.1 |
Gefitinib |
Sarcoma |
0.036596055 |
Sensitive |
| ENSG00000248773.1 |
Gefitinib |
Sarcoma |
0.028272562 |
Sensitive |
| ENSG00000250742.1 |
Gefitinib |
Sarcoma |
0.027671102 |
Sensitive |
| ENSG00000255367.1 |
Gefitinib |
Sarcoma |
0.03237549 |
Sensitive |
| ENSG00000256481.1 |
Gefitinib |
Sarcoma |
0.017377749 |
Sensitive |
| ENSG00000256712.1 |
Gefitinib |
Sarcoma |
0.02855459 |
Sensitive |
| ENSG00000258851.1 |
Gefitinib |
Sarcoma |
0.049785861 |
Sensitive |
| ENSG00000259336.1 |
Gefitinib |
Sarcoma |
0.047691788 |
Sensitive |
| ENSG00000259462.1 |
Gefitinib |
Sarcoma |
0.045081406 |
Sensitive |
| ENSG00000259959.1 |
Gefitinib |
Sarcoma |
0.045390781 |
Sensitive |
| ENSG00000260095.1 |
Gefitinib |
Sarcoma |
0.003535602 |
Sensitive |
| ENSG00000260132.1 |
Gefitinib |
Sarcoma |
0.006129536 |
Sensitive |
| ENSG00000260177.1 |
Gefitinib |
Sarcoma |
0.046847056 |
Sensitive |
| ENSG00000260400.1 |
Gefitinib |
Sarcoma |
0.03181963 |
Sensitive |
| ENSG00000260646.1 |
Gefitinib |
Sarcoma |
0.045509171 |
Sensitive |
| ENSG00000261168.1 |
Gefitinib |
Sarcoma |
0.040790523 |
Sensitive |
| ENSG00000262298.1 |
Gefitinib |
Sarcoma |
0.022850997 |
Sensitive |
| ENSG00000266401.1 |
Gefitinib |
Sarcoma |
0.042146519 |
Sensitive |
| ENSG00000266969.1 |
Gefitinib |
Sarcoma |
0.014758227 |
Sensitive |
| ENSG00000267064.1 |
Gefitinib |
Sarcoma |
0.008184142 |
Sensitive |
| ENSG00000268707.1 |
Gefitinib |
Sarcoma |
0.03393615 |
Sensitive |
| ENSG00000269887.1 |
Gefitinib |
Sarcoma |
0.049340873 |
Sensitive |
| ENSG00000271716.1 |
Gefitinib |
Sarcoma |
0.046304697 |
Sensitive |
| ENSG00000272263.1 |
Gefitinib |
Sarcoma |
0.008480203 |
Sensitive |
| ENSG00000273156.1 |
Gefitinib |
Sarcoma |
0.014545289 |
Sensitive |
| ENSG00000189238.4 |
Gefitinib |
Skin cutaneous melanoma |
0.045386344 |
Sensitive |
| ENSG00000223477.3 |
Gefitinib |
Skin cutaneous melanoma |
0.03381508 |
Sensitive |
| ENSG00000223485.1 |
Gefitinib |
Skin cutaneous melanoma |
0.019620256 |
Sensitive |
| ENSG00000223635.1 |
Gefitinib |
Skin cutaneous melanoma |
0.011414999 |
Sensitive |
| ENSG00000225111.1 |
Gefitinib |
Skin cutaneous melanoma |
0.009951567 |
Sensitive |
| ENSG00000225235.1 |
Gefitinib |
Skin cutaneous melanoma |
0.023619755 |
Sensitive |
| ENSG00000225798.1 |
Gefitinib |
Skin cutaneous melanoma |
0.022213488 |
Sensitive |
| ENSG00000225969.1 |
Gefitinib |
Skin cutaneous melanoma |
0.015722425 |
Sensitive |
| ENSG00000228113.3 |
Gefitinib |
Skin cutaneous melanoma |
0.026892234 |
Sensitive |
| ENSG00000228741.2 |
Gefitinib |
Skin cutaneous melanoma |
0.026780765 |
Sensitive |
| ENSG00000229373.4 |
Gefitinib |
Skin cutaneous melanoma |
0.028575197 |
Sensitive |
| ENSG00000229841.1 |
Gefitinib |
Skin cutaneous melanoma |
0.042384908 |
Sensitive |
| ENSG00000231563.1 |
Gefitinib |
Skin cutaneous melanoma |
0.01706421 |
Sensitive |
| ENSG00000232151.5 |
Gefitinib |
Skin cutaneous melanoma |
0.038261781 |
Sensitive |
| ENSG00000232807.2 |
Gefitinib |
Skin cutaneous melanoma |
0.009617082 |
Sensitive |
| ENSG00000232814.2 |
Gefitinib |
Skin cutaneous melanoma |
0.017755706 |
Sensitive |
| ENSG00000233799.1 |
Gefitinib |
Skin cutaneous melanoma |
0.028196914 |
Sensitive |
| ENSG00000234199.2 |
Gefitinib |
Skin cutaneous melanoma |
0.011032947 |
Sensitive |
| ENSG00000235664.1 |
Gefitinib |
Skin cutaneous melanoma |
0.013902751 |
Sensitive |
| ENSG00000235979.4 |
Gefitinib |
Skin cutaneous melanoma |
0.001121095 |
Sensitive |
| ENSG00000237685.1 |
Gefitinib |
Skin cutaneous melanoma |
0.005513978 |
Sensitive |
| ENSG00000237687.2 |
Gefitinib |
Skin cutaneous melanoma |
0.029933127 |
Sensitive |
| ENSG00000237976.1 |
Gefitinib |
Skin cutaneous melanoma |
0.01468934 |
Sensitive |
| ENSG00000238279.1 |
Gefitinib |
Skin cutaneous melanoma |
0.020530667 |
Sensitive |
| ENSG00000245479.2 |
Gefitinib |
Skin cutaneous melanoma |
0.018420928 |
Sensitive |
| ENSG00000248724.2 |
Gefitinib |
Skin cutaneous melanoma |
0.029641988 |
Sensitive |
| ENSG00000249803.1 |
Gefitinib |
Skin cutaneous melanoma |
0.037018191 |
Sensitive |
| ENSG00000253708.1 |
Gefitinib |
Skin cutaneous melanoma |
0.028576296 |
Sensitive |
| ENSG00000253799.1 |
Gefitinib |
Skin cutaneous melanoma |
0.011667217 |
Sensitive |
| ENSG00000254459.1 |
Gefitinib |
Skin cutaneous melanoma |
0.022672899 |
Sensitive |
| ENSG00000254842.2 |
Gefitinib |
Skin cutaneous melanoma |
0.049103298 |
Sensitive |
| ENSG00000255521.1 |
Gefitinib |
Skin cutaneous melanoma |
0.012298835 |
Sensitive |
| ENSG00000256128.1 |
Gefitinib |
Skin cutaneous melanoma |
0.031612032 |
Sensitive |
| ENSG00000257732.1 |
Gefitinib |
Skin cutaneous melanoma |
0.048266247 |
Sensitive |
| ENSG00000259182.1 |
Gefitinib |
Skin cutaneous melanoma |
0.029211128 |
Sensitive |
| ENSG00000259618.1 |
Gefitinib |
Skin cutaneous melanoma |
0.019819733 |
Sensitive |
| ENSG00000259656.1 |
Gefitinib |
Skin cutaneous melanoma |
0.034457335 |
Sensitive |
| ENSG00000259678.1 |
Gefitinib |
Skin cutaneous melanoma |
0.023177659 |
Sensitive |
| ENSG00000259771.1 |
Gefitinib |
Skin cutaneous melanoma |
0.04789273 |
Sensitive |
| ENSG00000260361.1 |
Gefitinib |
Skin cutaneous melanoma |
0.033916809 |
Sensitive |
| ENSG00000260597.1 |
Gefitinib |
Skin cutaneous melanoma |
0.009164783 |
Sensitive |
| ENSG00000260910.1 |
Gefitinib |
Skin cutaneous melanoma |
0.010697037 |
Sensitive |
| ENSG00000260911.1 |
Gefitinib |
Skin cutaneous melanoma |
0.037056413 |
Sensitive |
| ENSG00000260920.1 |
Gefitinib |
Skin cutaneous melanoma |
0.035133405 |
Sensitive |
| ENSG00000261043.2 |
Gefitinib |
Skin cutaneous melanoma |
0.008344883 |
Sensitive |
| ENSG00000261338.1 |
Gefitinib |
Skin cutaneous melanoma |
0.029997174 |
Sensitive |
| ENSG00000261425.1 |
Gefitinib |
Skin cutaneous melanoma |
0.047690005 |
Sensitive |
| ENSG00000262185.1 |
Gefitinib |
Skin cutaneous melanoma |
0.00535277 |
Sensitive |
| ENSG00000267654.1 |
Gefitinib |
Skin cutaneous melanoma |
0.045860851 |
Sensitive |
| ENSG00000267745.1 |
Gefitinib |
Skin cutaneous melanoma |
0.005203067 |
Sensitive |
| ENSG00000269194.1 |
Gefitinib |
Skin cutaneous melanoma |
0.033951942 |
Sensitive |
| ENSG00000271320.1 |
Gefitinib |
Skin cutaneous melanoma |
0.003667191 |
Sensitive |
| ENSG00000271344.1 |
Gefitinib |
Skin cutaneous melanoma |
0.030020103 |
Sensitive |
| ENSG00000272472.1 |
Gefitinib |
Skin cutaneous melanoma |
0.036360122 |
Sensitive |
| ENSG00000272562.1 |
Gefitinib |
Skin cutaneous melanoma |
0.039203322 |
Sensitive |
| ENSG00000273129.1 |
Gefitinib |
Skin cutaneous melanoma |
0.00929379 |
Sensitive |
| ENSG00000273454.1 |
Gefitinib |
Skin cutaneous melanoma |
0.017417666 |
Sensitive |
| ENSG00000203588.3 |
Gefitinib |
Stomach adenocarcinoma |
0.013619914 |
Sensitive |
| ENSG00000222041.6 |
Gefitinib |
Stomach adenocarcinoma |
0.026632812 |
Sensitive |
| ENSG00000223478.1 |
Gefitinib |
Stomach adenocarcinoma |
0.030438574 |
Sensitive |
| ENSG00000224063.1 |
Gefitinib |
Stomach adenocarcinoma |
0.037963041 |
Sensitive |
| ENSG00000224985.1 |
Gefitinib |
Stomach adenocarcinoma |
0.032267968 |
Sensitive |
| ENSG00000225643.1 |
Gefitinib |
Stomach adenocarcinoma |
0.044156414 |
Sensitive |
| ENSG00000226334.1 |
Gefitinib |
Stomach adenocarcinoma |
0.034617704 |
Sensitive |
| ENSG00000227375.1 |
Gefitinib |
Stomach adenocarcinoma |
0.049260798 |
Sensitive |
| ENSG00000230939.1 |
Gefitinib |
Stomach adenocarcinoma |
0.015261591 |
Sensitive |
| ENSG00000233854.1 |
Gefitinib |
Stomach adenocarcinoma |
0.001841023 |
Sensitive |
| ENSG00000233901.1 |
Gefitinib |
Stomach adenocarcinoma |
0.028500985 |
Sensitive |
| ENSG00000234665.4 |
Gefitinib |
Stomach adenocarcinoma |
0.02920297 |
Sensitive |
| ENSG00000234996.3 |
Gefitinib |
Stomach adenocarcinoma |
0.025628397 |
Sensitive |
| ENSG00000235560.3 |
Gefitinib |
Stomach adenocarcinoma |
0.046824351 |
Sensitive |
| ENSG00000236601.1 |
Gefitinib |
Stomach adenocarcinoma |
0.020780175 |
Sensitive |
| ENSG00000236810.1 |
Gefitinib |
Stomach adenocarcinoma |
0.041541118 |
Sensitive |
| ENSG00000236830.2 |
Gefitinib |
Stomach adenocarcinoma |
0.015791135 |
Sensitive |
| ENSG00000240350.1 |
Gefitinib |
Stomach adenocarcinoma |
0.036699669 |
Sensitive |
| ENSG00000248100.2 |
Gefitinib |
Stomach adenocarcinoma |
0.002997695 |
Sensitive |
| ENSG00000250608.1 |
Gefitinib |
Stomach adenocarcinoma |
0.022626418 |
Sensitive |
| ENSG00000257636.2 |
Gefitinib |
Stomach adenocarcinoma |
0.040175773 |
Sensitive |
| ENSG00000259048.1 |
Gefitinib |
Stomach adenocarcinoma |
0.03654217 |
Sensitive |
| ENSG00000261534.1 |
Gefitinib |
Stomach adenocarcinoma |
0.049539446 |
Sensitive |
| ENSG00000267288.1 |
Gefitinib |
Stomach adenocarcinoma |
0.003784184 |
Sensitive |
| ENSG00000267462.1 |
Gefitinib |
Stomach adenocarcinoma |
0.03543083 |
Sensitive |
| ENSG00000267672.1 |
Gefitinib |
Stomach adenocarcinoma |
0.036662765 |
Sensitive |
| ENSG00000267702.1 |
Gefitinib |
Stomach adenocarcinoma |
0.024086949 |
Sensitive |
| ENSG00000269463.1 |
Gefitinib |
Stomach adenocarcinoma |
0.03958792 |
Sensitive |
| ENSG00000269481.1 |
Gefitinib |
Stomach adenocarcinoma |
0.009924846 |
Sensitive |
| ENSG00000269640.1 |
Gefitinib |
Stomach adenocarcinoma |
0.045340283 |
Sensitive |
| ENSG00000269994.1 |
Gefitinib |
Stomach adenocarcinoma |
0.002546356 |
Sensitive |
| ENSG00000270933.1 |
Gefitinib |
Stomach adenocarcinoma |
0.002598274 |
Sensitive |
| ENSG00000272275.1 |
Gefitinib |
Stomach adenocarcinoma |
0.033512006 |
Sensitive |
| ENSG00000180769.4 |
Gefitinib |
Thyroid carcinoma |
0.029401702 |
Sensitive |
| ENSG00000203288.3 |
Gefitinib |
Thyroid carcinoma |
0.049953781 |
Sensitive |
| ENSG00000205628.2 |
Gefitinib |
Thyroid carcinoma |
0.033492933 |
Sensitive |
| ENSG00000205959.3 |
Gefitinib |
Thyroid carcinoma |
0.039874663 |
Sensitive |
| ENSG00000213468.3 |
Gefitinib |
Thyroid carcinoma |
0.046694247 |
Sensitive |
| ENSG00000223704.1 |
Gefitinib |
Thyroid carcinoma |
0.011760989 |
Sensitive |
| ENSG00000224216.1 |
Gefitinib |
Thyroid carcinoma |
0.033645297 |
Sensitive |
| ENSG00000224251.2 |
Gefitinib |
Thyroid carcinoma |
0.031137431 |
Sensitive |
| ENSG00000225077.2 |
Gefitinib |
Thyroid carcinoma |
0.018090475 |
Sensitive |
| ENSG00000225578.1 |
Gefitinib |
Thyroid carcinoma |
0.018636871 |
Sensitive |
| ENSG00000226332.2 |
Gefitinib |
Thyroid carcinoma |
0.025387515 |
Sensitive |
| ENSG00000226833.1 |
Gefitinib |
Thyroid carcinoma |
0.041627869 |
Sensitive |
| ENSG00000228043.1 |
Gefitinib |
Thyroid carcinoma |
0.045056176 |
Sensitive |
| ENSG00000229766.2 |
Gefitinib |
Thyroid carcinoma |
0.00816229 |
Sensitive |
| ENSG00000229956.5 |
Gefitinib |
Thyroid carcinoma |
0.045658088 |
Sensitive |
| ENSG00000230177.1 |
Gefitinib |
Thyroid carcinoma |
0.039163914 |
Sensitive |
| ENSG00000231865.1 |
Gefitinib |
Thyroid carcinoma |
0.015573736 |
Sensitive |
| ENSG00000232151.5 |
Gefitinib |
Thyroid carcinoma |
0.049057961 |
Sensitive |
| ENSG00000232504.4 |
Gefitinib |
Thyroid carcinoma |
0.03110902 |
Sensitive |
| ENSG00000232694.2 |
Gefitinib |
Thyroid carcinoma |
0.040650399 |
Sensitive |
| ENSG00000232874.1 |
Gefitinib |
Thyroid carcinoma |
0.031694707 |
Sensitive |
| ENSG00000233967.2 |
Gefitinib |
Thyroid carcinoma |
0.010706409 |
Sensitive |
| ENSG00000234899.5 |
Gefitinib |
Thyroid carcinoma |
0.004659553 |
Sensitive |
| ENSG00000236519.1 |
Gefitinib |
Thyroid carcinoma |
0.027587058 |
Sensitive |
| ENSG00000236986.2 |
Gefitinib |
Thyroid carcinoma |
0.043373756 |
Sensitive |
| ENSG00000237057.2 |
Gefitinib |
Thyroid carcinoma |
0.00808683 |
Sensitive |
| ENSG00000237940.3 |
Gefitinib |
Thyroid carcinoma |
0.021986431 |
Sensitive |
| ENSG00000240291.1 |
Gefitinib |
Thyroid carcinoma |
0.039948309 |
Sensitive |
| ENSG00000240453.1 |
Gefitinib |
Thyroid carcinoma |
0.046202903 |
Sensitive |
| ENSG00000240875.1 |
Gefitinib |
Thyroid carcinoma |
0.049526764 |
Sensitive |
| ENSG00000243485.2 |
Gefitinib |
Thyroid carcinoma |
0.023299949 |
Sensitive |
| ENSG00000248027.1 |
Gefitinib |
Thyroid carcinoma |
0.006981797 |
Sensitive |
| ENSG00000249042.1 |
Gefitinib |
Thyroid carcinoma |
0.021419549 |
Sensitive |
| ENSG00000250073.2 |
Gefitinib |
Thyroid carcinoma |
0.043094434 |
Sensitive |
| ENSG00000250909.1 |
Gefitinib |
Thyroid carcinoma |
0.000115077 |
Sensitive |
| ENSG00000253230.2 |
Gefitinib |
Thyroid carcinoma |
0.033526131 |
Sensitive |
| ENSG00000253559.1 |
Gefitinib |
Thyroid carcinoma |
0.03308364 |
Sensitive |
| ENSG00000253641.1 |
Gefitinib |
Thyroid carcinoma |
0.037238169 |
Sensitive |
| ENSG00000253649.1 |
Gefitinib |
Thyroid carcinoma |
0.010200028 |
Sensitive |
| ENSG00000254389.2 |
Gefitinib |
Thyroid carcinoma |
0.023176274 |
Sensitive |
| ENSG00000254577.1 |
Gefitinib |
Thyroid carcinoma |
0.027131044 |
Sensitive |
| ENSG00000254676.1 |
Gefitinib |
Thyroid carcinoma |
0.043196825 |
Sensitive |
| ENSG00000254812.1 |
Gefitinib |
Thyroid carcinoma |
0.039080463 |
Sensitive |
| ENSG00000254911.2 |
Gefitinib |
Thyroid carcinoma |
0.047583556 |
Sensitive |
| ENSG00000255983.1 |
Gefitinib |
Thyroid carcinoma |
0.00620932 |
Sensitive |
| ENSG00000256124.1 |
Gefitinib |
Thyroid carcinoma |
0.003050354 |
Sensitive |
| ENSG00000257151.1 |
Gefitinib |
Thyroid carcinoma |
0.048081876 |
Sensitive |
| ENSG00000257279.1 |
Gefitinib |
Thyroid carcinoma |
0.028323656 |
Sensitive |
| ENSG00000257647.1 |
Gefitinib |
Thyroid carcinoma |
0.040301425 |
Sensitive |
| ENSG00000258343.1 |
Gefitinib |
Thyroid carcinoma |
0.029660049 |
Sensitive |
| ENSG00000258443.1 |
Gefitinib |
Thyroid carcinoma |
0.046751407 |
Sensitive |
| ENSG00000258521.1 |
Gefitinib |
Thyroid carcinoma |
0.032284293 |
Sensitive |
| ENSG00000259416.2 |
Gefitinib |
Thyroid carcinoma |
0.031866081 |
Sensitive |
| ENSG00000259953.1 |
Gefitinib |
Thyroid carcinoma |
0.035798771 |
Sensitive |
| ENSG00000260163.1 |
Gefitinib |
Thyroid carcinoma |
0.033395917 |
Sensitive |
| ENSG00000260369.2 |
Gefitinib |
Thyroid carcinoma |
0.041630648 |
Sensitive |
| ENSG00000260394.2 |
Gefitinib |
Thyroid carcinoma |
0.01447789 |
Sensitive |
| ENSG00000260396.1 |
Gefitinib |
Thyroid carcinoma |
0.002436842 |
Sensitive |
| ENSG00000260404.2 |
Gefitinib |
Thyroid carcinoma |
0.041968257 |
Sensitive |
| ENSG00000260475.1 |
Gefitinib |
Thyroid carcinoma |
0.001082903 |
Sensitive |
| ENSG00000260774.1 |
Gefitinib |
Thyroid carcinoma |
0.033181562 |
Sensitive |
| ENSG00000260796.1 |
Gefitinib |
Thyroid carcinoma |
0.010891907 |
Sensitive |
| ENSG00000261118.1 |
Gefitinib |
Thyroid carcinoma |
0.047358792 |
Sensitive |
| ENSG00000261140.1 |
Gefitinib |
Thyroid carcinoma |
0.019323398 |
Sensitive |
| ENSG00000261288.1 |
Gefitinib |
Thyroid carcinoma |
0.01497955 |
Sensitive |
| ENSG00000261298.1 |
Gefitinib |
Thyroid carcinoma |
0.043958584 |
Sensitive |
| ENSG00000261840.1 |
Gefitinib |
Thyroid carcinoma |
0.048868612 |
Sensitive |
| ENSG00000263220.1 |
Gefitinib |
Thyroid carcinoma |
0.02885373 |
Sensitive |
| ENSG00000263916.1 |
Gefitinib |
Thyroid carcinoma |
0.041613892 |
Sensitive |
| ENSG00000264167.1 |
Gefitinib |
Thyroid carcinoma |
0.027317095 |
Sensitive |
| ENSG00000266912.1 |
Gefitinib |
Thyroid carcinoma |
0.026366797 |
Sensitive |
| ENSG00000267002.1 |
Gefitinib |
Thyroid carcinoma |
0.009212917 |
Sensitive |
| ENSG00000267025.1 |
Gefitinib |
Thyroid carcinoma |
0.047081711 |
Sensitive |
| ENSG00000267221.1 |
Gefitinib |
Thyroid carcinoma |
0.017954721 |
Sensitive |
| ENSG00000267730.1 |
Gefitinib |
Thyroid carcinoma |
0.044546137 |
Sensitive |
| ENSG00000267750.1 |
Gefitinib |
Thyroid carcinoma |
0.043177794 |
Sensitive |
| ENSG00000267778.1 |
Gefitinib |
Thyroid carcinoma |
0.005590648 |
Sensitive |
| ENSG00000269980.1 |
Gefitinib |
Thyroid carcinoma |
0.039005927 |
Sensitive |
| ENSG00000271151.1 |
Gefitinib |
Thyroid carcinoma |
0.001847825 |
Sensitive |
| ENSG00000271427.1 |
Gefitinib |
Thyroid carcinoma |
0.041569452 |
Sensitive |
| ENSG00000271430.1 |
Gefitinib |
Thyroid carcinoma |
0.012747032 |
Sensitive |
| ENSG00000271555.1 |
Gefitinib |
Thyroid carcinoma |
0.031764412 |
Sensitive |
| ENSG00000271778.1 |
Gefitinib |
Thyroid carcinoma |
0.040625602 |
Sensitive |
| ENSG00000271912.1 |
Gefitinib |
Thyroid carcinoma |
0.040790443 |
Sensitive |
| ENSG00000271963.1 |
Gefitinib |
Thyroid carcinoma |
0.036931087 |
Sensitive |
| ENSG00000271997.1 |
Gefitinib |
Thyroid carcinoma |
0.030943164 |
Sensitive |
| ENSG00000272438.1 |
Gefitinib |
Thyroid carcinoma |
0.004609492 |
Sensitive |
| ENSG00000272449.1 |
Gefitinib |
Thyroid carcinoma |
0.006533064 |
Sensitive |
| ENSG00000272732.1 |
Gefitinib |
Thyroid carcinoma |
0.040158269 |
Sensitive |
| ENSG00000272993.1 |
Gefitinib |
Thyroid carcinoma |
0.043756201 |
Sensitive |
| ENSG00000273058.1 |
Gefitinib |
Thyroid carcinoma |
0.003663342 |
Sensitive |
| ENSG00000273139.1 |
Gefitinib |
Thyroid carcinoma |
0.045563154 |
Sensitive |
